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Bacterial receiver domain proteins modulate the intracellular response to external stimuli 
in two-component systems. There is a new subclass of receiver domains associated with 
Histidine Tryptophan Glutamate kinases (HWE-kinases) that have divergent sequence 
properties. The enzyme Sma0114 is a receiver domain that is a substrate for an HWE-
kinase. The structure and dynamics of the Sma0114 protein were explored using nuclear 
magnetic resonance (NMR). Differences between the NMR structures of the inactive and 
activated states occur in helix α1, the active site loop that connects strand β3 and helix 
α3, and in the 455 (α4-β5-α5) face. In most receiver domains, the 455 face undergoes a 
structural rearrangement in the activated state to make it competent for binding 
downstream target molecules. Coupling between the 455 face and the active site 
phosphate is mediated through the rearrangement of a threonine and tyrosine residue via 
a mechanism called Y-T coupling. The NMR structure indicates that Sma0114 lacks Y-T 
coupling, and that communication between the active site and the 455 face is achieved 
through a conserved lysine residue that stabilizes the acyl phosphate in receiver domains. 
15N-NMR relaxation experiments reveal a loss of entropy due to binding ligands at the 
active site with compensating entropic increases in the 455 face. The dynamic character 
of the 455 face in Sma0114, which in part results from replacement of helix α4 by a 
flexible loop, may facilitate induced-fit binding of target molecules. 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Chapter One. Introduction 
 
Two-component systems mediate signal transduction in bacteria 
 Bacterial signal transduction is commonly accomplished using two-component 
systems that allow bacteria to sense changes in their environment and respond using 
highly sophisticated phosphorylation relays (1, 2).  The archetypal two-component 
system utilizes a histidine kinase that autophosphorylates itself in response to external 
stimuli and a response regulator that undergoes structural reorganization in response to 
phosphoryl transfer from its cognate histidine kinase (1). The histidine kinase component 
has two domains, an N-terminal external domain that senses environmental changes and 
an autokinase domain that autophosphorylates at a histidine residue. The response 
regulator component is located in the cytoplasm and also typically has two domains, a 
receiver domain that is phosphorylated by its cognate histidine kinase and an effector 
domain that carries out an output response that usually involves DNA binding to affect 
gene transcription. Receiver domains have a conserved α5/β5 Rossmann fold, where 5 α-
helices surround 5 parallel β-sheets whereas effector domains vary among response 
regulators according to their downstream function.  
 
Receiver domains have a conserved structure in response regulator proteins 
 Receiver domains have several conserved sequence motifs: (I) a pair of acidic 
residues in the β1/α1 loop (Lβ1/α1) that coordinate a divalent metal cation, (II) an aspartate 
at the C-terminal end of strand β3 that serves as the phosphorylation site, (III) a threonine 
at the C-terminal end of strand β4 that hydrogen bonds with the phosphate moiety via its 
sidechain hydroxyl group, (IV) an aromatic (tyrosine or phenylalanine) in strand β5 that 
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rotates its aromatic ring toward the hyrdophobic core upon reorientation of the threonine 
sidechain and (V) a lysine that flips its sidechain toward the phosphate group to provide a 
stabilizing salt bridge upon phosphorylation. The conserved features are highlighted on 
the ribbon diagram of sporulation factor Spo0F, a receiver domain from Bacillus subtilis 
in Figure 1-1. The role of the receiver domain is to accept a phosphate from its cognate 
histidine kinase forming a high-energy phospho-Asp bond that triggers the activation of 
the enzyme (1, 3). As such, the receiver domain acts as a “switch” that undergoes a 
conformational change in response to phosphorylation (1, 2).  The effector domain 
typically mediates the downstream output response that is often DNA binding to affect 
gene expression (1, 2).    
 A smaller subset of about 15% of response regulators are single domain proteins, 
containing only the receiver domain (4-6).  Of the ~30,000 non-redundant receiver 
domain sequences known, ~200 have been structurally characterized (4). Some single 
domain proteins housing only a receiver domain include CheY and Spo0F (1, 7, 8). The 
roles of single domain response regulators are not as well understood as their two-domain 
counterparts but there are three known functions. The receiver domain can act directly on 
a protein effector such as in the case of CheY, it can participate in a phospho-relay 
cascade as in the case with Spo0F, or it can act as a histidine kinase inhibitor as in the 
case with DivK (5, 9, 10).  Structural studies of receiver domains have shown that these 
are structurally similar in their inactive apo forms but show greater variability in their 
phosphorylated activated states (11).  This is likely because the function of the inactive 
receiver domain is to receive a phosphate from its cognate histidine kinase, whereas the 
activated enzyme can bind to a wide range of downstream effector proteins (12, 13). 
  3 
 
 
 
Figure 1-1 Structure of the receiver domain Spo0F. The α/β topology consists of a five-
stranded parallel β-sheet surrounded by five α-helices. Conserved features of the active 
site are highlighed in red (I) metal binding site, in green (II) the phosphorylation site, in 
pink (III) the Thr of Y-T coupling, in purple (IV) the aromatic Phe of Y-T coupling and 
in blue (V) the Lys that forms a salt bridge with the phosphate. PDB codes 1NAT and 
1PUX correspond to the inactive and activated structures respectively.  
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Activation of Receiver Domains 
 Activation of receiver domains is accomplished by phosphorylation at a 
conserved aspartate in the presence of a divalent metal ion such as Mg2+, Mn2+, or Ca2+ 
(14). A conserved pair of acidic residues located in the loop between strand β1 and helix 
α1, form part of the binding site for a divalent metal cation which is required for 
stabilizing the incoming phosphate group and forming the acyl-phosphate linkage (2, 4). 
The site of phosphorylation is a conserved Asp at the C-terminal end of strand β3 (1, 2). 
The C-terminal end of strand β5 houses a conserved Lys that stabilizes the incoming 
phosphate group (4).  Upon phosphorylation, receiver domains undergo a conformational 
transition to an activated state, becoming primed for binding the downstream effector 
molecules that elicit the signal transduction output response. Receiver domains have 
autophosphatase enzymatic activity that controls the lifetime of the activated state, and 
hence the duration of the output response (15, 16). 
 In typical receiver domains, the phosphorylation state of the active site is 
communicated to the output 455 (α4-β5-α5) face of the enzyme that typically forms a 
binding surface for downstream targets. Activation of the protein is relayed to the 455 
face through a conformational rearrangement called 'Y-T coupling', involving a 
structurally conserved tyrosine (Y) and threonine (T) (1). In this mechanism a Thr in 
strand β4 forms a hydrogen bond with the phosphate via its sidechain hydroxyl group. 
The cavity left by the Thr sidechain reorientation is filled by the reorientation of an 
aromatic sidechain (Tyr/Phe) from a residue in strand β5 (Figure 1-1). Upon activation 
the enzyme undergoes a structural rearrangement commonly in the 455 face. The receiver 
domain is then primed to carry out the output response.    
  5 
Sma0114 deviates from known receiver domain enzymes   
 The two-component system encoded by the genes sma0113 and sma0114 from 
the bacterium Sinorhizobium meliloti, was identified in a genetic screen for altered 
succinate-mediated catabolite repression (17). S. meliloti is a gram-negative soil 
bacterium in the α-proteobacteria. The bacterium can exist in the soil as a free-living 
organism, or it can live as a nitrogen-fixing symbiont in specialized organs called 
nodules, that it induces on the roots of certain legumes such as alfalfa. Based on previous 
work it is expected that sma0113 and sma0114 play a role in S. meliloti catabolite 
repression and polyhydroxy butyrate synthesis (17). The tandem genes encode a 
histidine-tryptophan-glutamate (HWE) histidine kinase (Sma0113), and a single-domain 
response regulator (Sma0114).  
 The architecture of the classic histidine kinase involves two modular domains 
termed the dimerization and catalytic domains. The dimerization domain is a helix bundle 
and the catalytic domain has a mixed α/β topology with five β-strands and three α-
helices. In archetypal histidine kinases the H box that houses the conserved His for 
autophosphorylation is located in the dimerization domain (1).  The catalytic domain is 
responsible for ATP binding and contains several conserved sequence motifs. The N, G1, 
G2 and F boxes are amino acid motifs involved in nucleotide binding (1, 2).   
 HWE-kinases were first described in 2004 (18) and constitute a subclass of the 
larger histidine kinase superfamily. Compared to the well-characterized histidine kinase 
family, HWE-kinases have an altered ATP binding site, which lacks the F box that is 
normally an integral component of the ATP lid. There is a His in what appears to be the 
H box of the HWE-kinase, however, there is little alignment between this H box and 
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known H box sequences. Furthermore, there is a His in the N box as well as Trp and Glu 
residues in the G1 box of the protein (18). The His, Trp and Glu resides in the H and G1 
boxes are essential for autophosphorylation of the HWE-kinase family.  
 Preliminary sequence analysis of Sma0114 reveals that it adopts a prototypical 
Rossmann-fold but has features that set it apart from other receiver domains. Sma0114 
has many conserved residues typically present in receiver domains including the Asp 
(Asp60) that accepts a phosphate from its cognate HWE-kinase Sma0113 and a pair of 
acidic residues involved in prototypical metal binding (Glu15 and Asp16).  One 
interesting feature of Sma0114 is the presence of a new motif PFxFATGY located in the 
beta strand that houses the Thr typically involved in the classic Y-T coupling mechanism.  
Although the conserved Thr is present in the sequence, Sma0114 does not have the 
conserved aromatic residue that is the other half of this coupling motif. 
 The NMR investigations described herein show that the unusual sequence features 
of Sma0114 lead to unique structural features, primarily affecting the 455 face of the 
enzyme. 15N relaxation data show that there are also changes in the dynamics of the 455 
face of Sma0114 compared to the corresponding regions of other receiver domains (19, 
20). By contrast the active site of the enzyme and the ability to bind metals is retained, 
suggesting that the unusual features of Sma0114 do not alter the activation mechanism 
but rather the conformational changes of the 455 face accompanying phosphorylation. 
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Chapter 2. Chemical Shift Assignments for Sma0114 
 
 
Abstract 
 Response regulators of bacterial two-component systems undergo extensive 
structural reorganization in response to phosphoryl transfer from their cognate histidine 
kinases.  The response regulator encoded by the gene sma0114 of S. meliloti is a part of a 
unique class of two-component systems that employ HWE histidine kinases.  The distinct 
features of Sma0114 include a PFxFATGY motif that houses the conserved threonine in 
the “Y-T coupling” conformational switch and the replacement of the conserved Phe/Tyr 
in Y-T coupling by a Leu. Presented here are 1H, 15N, and 13C NMR assignments for 
Sma0114. Chemical shift assignments are a pre-requisite for an NMR study. Secondary 
structural elements of the protein were identified based on TALOS chemical shift 
analysis, 3JHNHa coupling constants and hydrogen-deuterium exchange.  The secondary 
structure determined by NMR is in good agreement with that predicted from the 
sequence.  
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Introduction 
   Receiver domains of response regulators are typically about 110 amino acids 
long and are structurally and functionally analogous to members of the Ras family of 
small eukaryotic GTPases (21).  It was expected that the 120 amino acid (13.5 kDa) 
Sma0114 protein would have a CheY-like structure, belonging to the α/β Rossmann-fold 
superfamily.  Regulatory regions of Sma0114 were identified via comparison to known 
receiver domains and include a set of conserved residues clustered in an active site at the 
C-terminal edge of the β-sheet. Two additional conserved amino acids include a 
hydroxylic residue (Ser/Thr) and an aromatic residue (Phe/Tyr) that play direct roles in 
communication between the active site and output response α4-β5-α5 (455) face of the 
protein. The Y-T coupling mechanism thus transforms the overall character of the 455 
face of the protein.  The conformational transition in turn governs the specific 
interactions that mediate the output response (22-24).  
Sma0114 is a member of a recently identified class of response regulators 
associated with HWE-kinases. Response regulators associated with the HWE kinases 
(25) either because the two components are linked on the same polypeptide chain or 
encoded in the same operon like the Sma0113(histidine kinase)/114 (response 
regulator)pair, often have a conserved motif at the C-terminal end of strand β4. Response 
regulators containing this PFxFATGY, or “FAT GUY” motif have not been structurally 
characterized. To better understand the unique features of Sma0114 including the non-
conserved Y-T coupling mechanism, the role of the PFxFATGY motif, and activation by 
its cognate HWE kinase an NMR characterization of the structure and dynamics of the 
protein was undertaken.  
  9 
Results 
Backbone Chemical Shift Assignments 
  A series of NMR experiments were used to obtain chemical shift assignments for 
the enzyme. Several through-bond (TOCSY-type) experiments were used initially to 
establish backbone resonance assignments in Sma0114.  Specifically, two redundant 
sequential walk pathways were used. Using multiple pathways ensured the accuracy of 
the resonance assignments. The first pathway used Cα connections via HNCA and 
HN(CO)CA experiments. The second pathway used backbone carbonyl connections via 
HNCO and HN(CA)CO experiments. HNCACB experiments were used in conjunction 
with the Cα and carbonyl sequential walk methods. The HNCACB experiment was used 
to correlate the Cα and Cβ resonances of a single residue using through-bond coupling to 
the Cα and Cβ of the preceding residue in the sequence. Using this method, full chemical 
shift assignments were obtained. Figure 2-1 illustrates example resonances from the 
HNCACB spectrum of the inactive enzyme. Using these multidimensional NMR 
experiments backbone amide resonances were assigned in a 2D 1H-15N HSQC of 
Sma0114. The 2D 1H-15N HSQC spectrum is unique to a polypeptide chain and provided 
a platform with which to characterize other atomic assignments. The 1H-15N HSQC 
experiment is the most ubiquitously used spectrum to identify a protein and is often used 
to establish amino acids involved in substrate binding. Backbone 1H-15N assignments for 
apo-Sma0114 are summarized in Figure 2-2.   
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Figure 2-1  HNCACB Spectra for the sequence Arg78-Glu77-Ala76-Leu75-Ile74. 
Greater intensity Cα and Cβ peaks in each panel correspond to the residue X. Lower 
intensity Cα and Cβ resonances belong to the residue X-1 in the amino acid sequence. 
For example, the R78 panel contains contours corresponding to the Cα and Cβ chemical 
shifts for Arg78 as well as lower intensity Cα and Cβ resonances belonging to Glu77. In 
this sequential walk manner 1H and 15N as well as Cα and Cβ chemical shifts were  
determined. Dotted green lines in each panel identify the spin systems. Blue and red 
resonances represent Cα and Cβ peaks respectively.  
  11 
Sidechain Chemical Shift Assignments  
 Sidechain resonances were also assigned using 3D through-bond correlation 
(TOCSY) experiments. Manual assignments using HCCH-TOCSY experiments, 
described by Kay, L.E. et al. were employed first, however, the lower resolution of the 
experiments made unambiguous assignments difficult and tedious. For example, 
resolving methyl group 1H resonances to unique residues was particularly challenging. In 
order to make unambiguous assignments for aliphatic sidechain 13C and 1H resonances 
we used the approach described by Sun, Z.Y. et al (26).  The described 3D HCCONH and 
CCONH experiments correlate aliphatic proton and carbon resonances with the HN 
group of each residue in the sequence. The HN correlation provides the unambiguous 
avenue for sidechain assignments as each amino acid has one unique HN chemical shift 
(Figure 2-2). Sidechain chemical shifts were necessary to provide comprehensive 
assignments for the enzyme to be used in through-space or NOESY-type experiments. 
Unambiguous assignments helped improve the precision of the NMR structure of the 
enzyme. 
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Figure 2-2 1H-15N HSQC spectrum of Sma0114.  Backbone assignments are indicated 
with pink labels.  Peaks that could only be seen at contours lower than shown (M4, E17) 
are denoted by squares.  Side chains amide resonances are indicated with blue dashed 
lines and labels, with the superscript SC.  Data were collected at pH 6.0 and a 
temperature of 37°C. 
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Secondary Structure of Sma0114 
 Following chemical shift assignments for backbone and sidechain residues, 
secondary structure predictions were performed using PSIPRED (27). These data are 
summarized in Figure 2-3.  The secondary structure established by NMR agrees with the 
secondary structure predicted from the sequence using the PSIPRED server (27).  Both 
methods indicated that helix α4 of the prototypical CheY-fold, was absent in Sma0114 
(corresponding to residues 90-99).  The 455 face of response regulators is critical in 
transmitting the kinase phosphorylation signal to downstream binding partners (24, 28), 
so the absence of helix α4 in Sma114 led to the conclusion that there was a new distinct 
mechanism of coupling between HWE kinases and their cognate response regulators. 
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Figure 2-3 Secondary structure of Sma0114.  (A) Amino acid sequence of Sma0114, 
amide protons protected from exchange after 2 hour in D2O at pH 6.0 and 37 oC, TALOS 
predictions of secondary structure based on HN, N, Hα, Cα, Cβ and C’ chemical shifts 
(29), and secondary structure predicted using the PSIPRED server (27).  (B) Cα chemical 
shifts minus random coil values (30).  Positive deviations correspond to α-helix, negative 
to β-sheet. (C) Cβ chemical shifts minus random coil values (30).  Negative deviations 
correspond to α-helix, positive to β-sheet. (D) 3JHNHα couplings obtained from a 3D 
HNHA experiment, presented as 3JHNHα – 7 Hz.  Positive and negative differences 
correspond to β-sheet and α-helix secondary structure, respectively. 
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              Reprinted from Sheftic et al. 2012 (31) 
              I performed all experiments except the secondary structure prediction Figure 3-5 
 
Chapter Three. NMR Structure and Dynamics of Apo-Sma0114 
 
Abstract 
 The solution NMR structure and dynamics of Sma0114 from the bacterium S. 
meliloti is described. This is the first such characterization of a receiver domain from the 
HWE-kinase family of two-component systems. The structure of Sma0114 adopts a 
Rossmann-fold but has features that set it apart from other receiver domains. Sma0114 
lacks the fourth α-helix of the consensus 455 face and 15N relaxation data show that it is 
replaced by a segment that is flexible on the ps-ns timescale. Secondary structure 
prediction of Sma0114 and other HWE-kinase-associated receiver domains suggests that 
the absence of helix α4 may be a conserved property of this family. In spite of these 
differences, Sma0114 has a conserved active site, binds divalent metal ions such as Mg2+ 
and Ca2+ that are required for phosphorylation, and exhibits µs-ms active site dynamics 
similar to other receiver domains.  
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Introduction 
 In order to correlate the new sequence features of Sma0114 with changes in 
tertiary structure we solved the solution NMR structure of the enzyme. Presented here is 
the 3-dimensional structure of Sma0114 in the apo state.  The NMR data support the 
secondary structure predictions presented in Chapter 2 and prove that the topology of the 
protein deviates from an α5/β5 fold to an α4/β5 fold. The missing α-helix maps to the area 
of the protein that based on sequence alignments would house helix α4, the first 
constituent of the 455 face.  
 15N T1, T2, and NOE relaxation data were used as input for a Model-Free 
simulation that provides information on the amplitude (S2 order parameter) and timescale 
of bond motions (32).  Dynamics data are compared between the inactive and activated 
protein (Chapter 4) to assess the role of flexibility in enzyme function. Dynamics of the 
apo-protein reveal that the loop replacing helix α4 between strands β4 and β5 is flexible 
on the ps-ns timescale, indicative of fast motions similar to those seen for protein N and 
C-termini. Analysis of µs-ms dynamics reveal four distinct regions of the protein that 
have increased R2ex terms, indicative of conformational exchange.  
 We performed a metal titration in order to determine saturating concentrations of 
a divalent cation required to stabilize the acyl-phosphate linkage in the active site of 
Sma0114. Our initial profile of chemical shift changes in 1H-15N HSQC spectra upon 
Mg2+ binding showed a weak affinity for the metal ion. The unusually high (150 mM) 
concentration of MgCl2 required to saturate the metal binding site led to a loss in 
signal/noise during data acquisition presumably due to the increase in salt concentration 
within the sample. In order to circumvent the use of high metal concentrations, CaCl2 was 
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titrated into Sma0114 samples in order to determine the affinity of the enzyme for Ca2+. 
A concentration of 1.5 mM CaCl2 was required to saturate the metal binding site 
indicating preferential binding of Ca2+ for Sma0114.  
 The NMR investigations described herein show that the unusual sequence features 
of Sma0114 lead to unusual structural features, primarily affecting the 455 face of the 
enzyme. 15N relaxation data show that there are also changes in the dynamics of the 455 
face of Sma0114 compared to the corresponding regions of other receiver domains (19, 
20). By contrast the active site of the enzyme and the ability to bind metals is retained.  
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Results 
Solution NMR Structure of Apo-Sma0114  
 Structure statistics for the NMR models calculated are given in Table 3-1. Figure 
3-1 shows the NMR structure of Sma0114. The overall fold of the protein is similar to the 
canonical α5/β5 Rossman-fold of other receiver domains, which is schematically 
illustrated in Figure 3-1A.  Backbone (Cα, N, C') traces of the 20 lowest energy NMR 
structures of Sma0114 are shown in Figure 3-1B. 
 The NMR structure of Sma0114 closest to the ensemble average is compared with 
that of a typical receiver domain Spo0F in Figures 2C and 2D, respectively. The 
deviations from the canonical receiver domain fold occur primarily along the 455 face of 
Sma0114.  The most conspicuous difference in Sma0114 (Figure 3-1C), is that helix α4 is 
replaced by a disordered segment (residues 88-93).  Another difference, is that strand β5 
which is shorter than the other β-strands due to two flanking proline residues (P101, 
P106), turns inward toward the core of the Sma0114 structure (Figure 3-1C). 
 To look more closely for similarities and differences to other receiver domains, 
the DALI server (33) was used to find the 10 best structural matches to Sma0114. The 10 
best matches were all structures of inactive states of receiver domains, and had an 
average backbone RMSD of 3.17 Å to our Sma0114 structure over an average alignment 
length of 99 residues.  The most prominent difference in Sma0114 is the absence of helix 
α4 (Figure 3-1C). Another important change is that the loop following strand β3 appears 
to cover and possibly restrict access to the phosphorylation site residue, Asp60 (Figure 3-
1C), whereas it extends away from the hydrophobic core in the homologous structures 
(Figure 3-1D).  
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Table 3-1: Statistics for the 20 Lowest Energy NMR Structures of Sma0114 
NMR restraints (total)     1627     
Distance (total)      1431 
 Intraresidue NOEs     422 
 Sequential NOEs      486 
 Short range NOEs (1< |i-j| < 5)    109 
 Long range NOEs (5 < |i-j|)    414 
 Hydrogen bonds (32x2)    64 
Dihedral (ϕ 61, ψ 54, χ1 17)      132 
Residual restraint violations 
NOE (Å)1       0.039 ± 0.004 
Dihedral (°)2       0.539 ± 0.018 
RMS deviations from ideal geometry 
Bonds (Å)       0.0040 ± 0.0003  
Angles (°)       0.73 ± 0.02 
Improper torsions (°)      0.54 ± 0.02 
Van der Waals energy (kcal/mol)3    86.28 ± 2.37 
Lennard-Jones energy (kcal/mol) 4    -83.18 ± 7.40 
ProcheckNMR Z-score5     -2.52 
Ramachandran plot 
 most favored (%)     82.3 
 allowed (%)      15.3 
 generously allowed (%)    1.8 
 disallowed  (%)     0.6 
Coordinate RMS deviations (Å) 
NMR ensemble to average      Cα, C, N  All Heavy 
Entire domain (110 residues)6     0.94  1.46 
Excluding loops (72 residues) 7    0.86  1.38 
 
 
_________________________________________________________________________ 
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1 Structure contains no NOE violations greater than 0.3Å 
2 Structure contains no dihedral violations greater than 5° 
3 Evdw was calculated using the X-PLOR Frepel function (34) with van der Waals interactions and 
atomic radii set to 0.8 times their CHARMM (35) values.  
4 EL-J was calculated using the CHARMM empirical energy function (35) 
5ProcheckNMR used via Protein Structure Validation Suite (PSVS) (36)  
6 Excluding N-terminus (residues 1-9) and C-terminus (residues 118-123) 
7 Only residues in regular secondary structure (10-15, 19-31, 34-39, 42-51, 56-60, 70-78, 81-86, 
102-105, 108-117) 
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The alignment to structurally homologous proteins using the DALI server (33) also 
indicates that the C-terminal portion of the PFxFATGY motif in Sma0114 differs from 
the corresponding region in the canonical receiver domain fold.  The PFxFATGY motif is 
highlighted in cyan on the NMR structure of Sma0114 in Figure 3-2A.  This motif 
encompasses all of strand β4 and forms the beginning of the loop between strands β4 and 
β5. The conserved Thr86 of the Y-T coupling pathway is part of this motif and is the last 
residue in strand β4 (shown in purple in Figure 3-2A). The partner aromatic residue in the 
Y-T coupling mechanism is replaced by a Leu103 in strand β5 (shown in black in Figure 
3-2A).  The absence of the conserved aromatic residue has also been seen in the single 
domain response regulator CheY2 from S. meliloti, an enzyme that has been reported to 
lack Y-T coupling (37).   These changes provide compelling evidence that the 
prototypical Y-T coupling mechanism is altered in Sma0114. 
 The two residues of the PFxFATGY motif that form part of the loop immediately 
following strand β4 (Gly87 and Tyr88) show large structural differences in Sma0114 
compared to the top 10 structural similarity hits.  These two residues are located 
immediately before the start of the disordered segment that replaces helix α4 in Sma0114.  
The C-terminal portion of the PFxFATGY motif in Sma0114 superimposes with the N-
terminal portion of helix α4 in the 10 closest structural matches.  Together with the 
placement of the Y-T coupling threonine, this suggests that at least the C-terminal part of 
the PFxFATGY motif belongs to the 455 face of Sma0114. 
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Figure 3-1 Fold and NMR structure of Sma0114.  (A) Topology diagram for the 
canonical α5/β5 Rossman fold of receiver domains.  Parallel β-sheets (blue) are 
surrounded by α-helices (green) with pink segments indicating loops.  The fourth α-helix 
which is disordered in Sma0114 is also indicated in pink.  (B) Backbone representation of 
the 20 lowest energy NMR structures. Regular secondary structure elements 9-15 (β1), 
19-31 (α1), 34-39 (β2), 42-51 (α2), 55-60 (β3), 70-78 (α3), 81-86 (β4), 102-105 (β5), 
110-117 (α5) were used to superimpose the structures. (C) NMR structure of Sma0114 
closest to the ensemble average.  The fourth α-helix is replaced by a disordered segment. 
(D) NMR structure of Spo0F (PDB accession code 1NAT) (38).  The fourth α-helix is 
shown in pink.  N and C termini are noted in (C) and (D) with N and C respectively. 
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Figure 3-2 Active site of Sma0114.  (A) Stereo-diagram of the NMR structure of 
Sma0114 closest to the ensemble average, showing selected sidechains of active site 
residues: metal-ligands Glu15 and Asp16 in red, the phosphorylation site Asp60 in green, 
and Thr86 and Leu103 of the Y-T coupling pair in purple and pink, respectively. The 
PFxFATGY motif is shown in cyan. (B) Stereo-view of the 20 lowest energy NMR 
structures of Sma0114 illustrating the precision of sidechains from different parts of the 
molecule.  Sidechains comprising the hydrophobic core (blue) are well defined while 
those of active-site residues (color scheme as above) show poorer precision due to 
increased dynamics on the µs-ms timescale. 
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 While the 455 face of the enzyme shows deviations from the receiver domain 
superfamily, the active site of Sma0114 has features consistent with other receiver 
domains (Figure 3-2A).  The metal binding residues, Glu15 and Asp16, are located at a 
conserved position in the loop between β1 and α1 (11, 13, 39).  The phosphorylation site 
(Asp60) is at the C-terminal end of β3 like in other receiver domains.  The hydroxylic 
residue (Thr86) that hydrogen bonds with the incoming phosphate in the Y-T coupling 
mechanism is located at the C-terminal end of strand β4.  The basic residue Lys105, 
which typically stabilizes the activated state by forming a salt bridge with the incoming 
phosphate occurs in a conserved location in strand β5.    
  Strands β1-β4 and helices α1-α3 have the highest precision in the NMR structure 
(Figure 3-2B).  Regions with lower precision occur in the 455 face and include the 
segments corresponding to helix α4, strand β5, and helix α5.  The active site of Sma0114 
also has lower precision in the NMR structure, as illustrated in Figure 3-2B which 
compares sidechains of residues in the active site and in the hydrophobic core of the 
protein.  The equilibrium shift theory of activation hypothesizes that receiver domains 
exist in their inactive and active substates simultaneously in solution.  Activation via 
phosphorylation shifts the population from the inactive to the active form (4, 20).  It 
follows that that the active site, which is experiencing exchange between inactive and 
active conformational substates on a µs-ms timescale, would have a lower precision due 
to R2ex line broadening.  To verify that the lower precision of the active site and 455 face 
in the NMR structure of Sma0114 is due to genuine flexibility, as it is in other receiver 
domains (39, 40), we characterized the backbone dynamics of the protein using 15N 
relaxation data. 
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 NMR Relaxation Data Show Increased Flexibility for the 455 Face and Active Site  
 Relaxation data for Sma0114 are shown in Figure 3-3.   The R1 values are 
roughly constant over the length of the protein with a mean value of 2.00 ± 0.01 s-1, 
except for raised rates in the region between residues 89 and 99, which also shows 
lowered 1H-15N NOEs (Figure 3-3A).  The R2 data reveal four distinct regions that have 
relaxation contributions greater than the mean value of 8.0 ± 0.3 s-1, as indicated in 
Figure 5B. The mean 1H-15N NOE value is 0.75 ± 0.01, close to the theoretical maximum 
of 0.80 (41).  Lowered 1H-15N NOEs are seen for the chain termini and the region 
between residues 88 and 95 that corresponds to the missing helix α4 (Figure 3-3C).   
To interpret the relaxation data in terms of backbone dynamics we performed a 
Model-Free analysis (42) using the program Tensor2 (Figure 3-4).  We obtained a 
correlation time of 5.1 ns for Sma0114, consistent with a monomeric protein of 13.5 
KDa.  The S2 values which describe the amplitudes of internal motions on the ps-ns 
timescale are shown in Figure 3-4A and are mapped on the NMR structure in Figure 3-
4B. Except for the chain termini, the only region in the protein with low S2 order 
parameters is the flexible segment that replaces helix α4 (Figure 3-4A).  The R2ex terms 
that describe exchange contributions to R2 relaxation from dynamics on the µs-ms 
timescale are shown in Figure 3-4C and are mapped on the NMR structure in Figure 3-
4D. Residues that experience significant R2ex contributions cluster to four region of the 
protein: (I) the metal binding site, (II) the phosphorylation site, (III) Thr86 which is 
predicted to hydrogen bond with an incoming phosphate in the Y-T coupling mechanism, 
and (IV) Lys105 which stabilizes the incoming phosphate through a salt-bridge. Thus all 
four regions with R2ex contributions are in the active site of the enzyme, which has been 
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shown for other receiver domains to be subject to µs-ms timescale interconversion 
between inactive and active substates as described in the equilibrium shift theory of 
activation (19, 20). 
Despite their strong structural homology, receiver domains from various two-
component systems exhibit different dynamics on the µs-ms timescale.  R2ex terms for 
Spo0F, an intermediate in the sporulation relay of B. subtilis, are larger for the metal 
binding site compared to the 455 face of the enzyme (19).  Conversely, in NtrC, the 
nitrogen regulatory response regulator from S. typhimurium, R2ex contributions are large 
for the 455 face of the enzyme whereas the metal binding site shows no exchange 
broadening (6, 20).  The R2ex profile of Sma0114 differs from Spo0F and NtrC in that it 
shows exchange broadening not only in the metal-binding and phosphorylation sites but 
also in the β5 and α5 regions of the conserved 455 face. 
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Figure 3-3 15N NMR relaxation data for Sma0114.  (A) R1 rates. (B) R2 rates. (C) 1H-
15N NOE values.  Error bars are shown for all data points but in some cases are smaller 
than the symbols used to depict the data.  The secondary structure of Sma0114 is 
indicated with arrows (β-sheets) and cylinders (α-helices) in each panel. 
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Figure 3-4 Model-free analysis of Sma0114. (A) S2 order parameters. (B) S2 order 
parameters mapped onto the NMR structure of Sma0114. The color map goes from blue 
(rigid) to red (flexible). (C) R2ex values. (D) R2ex values mapped onto the NMR structure 
of Sma0114 with colors ranging from blue (negligible R2ex contributions) to red (large 
R2ex contributions). Residues for which no data were available are shown in black. 
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The Family of Receiver Domains Associated with HWE-Kinases is Predicted to Lack 
Helix α4  
 The NMR structure of Sma0114 is the first of an HWE-kinase associated receiver 
domain.  Due to the unusual features of this enzyme we performed a bioinformatics 
analysis to determine if the absence of helix α4 is a conserved property of this subfamily.  
The structure prediction program PsiPred (43) was used to evaluate the secondary 
structure of 84 receiver domains with cognate HWE-kinase partners.  Of the 84 proteins 
considered, 71 were predicted to lack helix α4 (Figure 3-5A).  A subset of 13 HWE-
associated receiver domains are predicted to have helix α4 but then appear to lack the last 
helix α5 (Figure 3-5B). This suggests that most of the HWE-associated receiver domains 
in which helix α4 is present, have compensatory perturbations that disrupt helix α5 of the 
455 face. By contrast, all of the α-helices and β-strands of the consensus Rossman fold 
are accurately predicted by the PsiPred program for a control group of 8 receiver domains 
of known structure that are not associated with HWE-kinases (Figure 3-5C).  
 
Sma0114 Binds Mg2+ and Ca2+  
 We next wanted to see if divalent cations, which are required for the stabilization 
of the acyl-phosphate linkage (4, 14), are able to bind to Sma0114 in spite of the 
differences seen for the 455 face.  Several groups have used Mg2+ to study the metal-
bound states of receiver domains (11, 13, 44).  In the case of Sma0114 we found that 
Mg2+ binds very weakly, with a Kd near 75 mM and saturation at 150 mM Mg2+.  The 
MgCl2 concentration required to stabilize the fully metal bound state leads to a decrease 
in sensitivity for NMR experiments due to high solution ionic strength, especially for data  
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Figure 3-5 Secondary structure prediction of 84 HWE-associated receiver domains. Each 
row corresponds to one receiver domain. (A) Subset of 71 receiver domains with cognate 
HWE-kinases, all of which are predicted to be missing helix α4. Sma0114 is at the top of 
the figure labeled with an arrow. (B) Subset of 13 HWE-associated receiver domains 
predicted to have helix α4. Note that most of the members of this subset are predicted to 
be missing the alternate helix α5 of the 455 face. (C) Control group of 8 receiver domains 
of known α5/β5 structures used to verify the secondary structure prediction algorithm. 
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collection with a cryogenic probe. An additional problem is that the large Mg2+ 
concentration needed to saturate Sma0114 causes non-specific binding to clusters of 
acidic residues in the protein. Finally, Sma0114 is more susceptible to aggregation on the 
timescale of days to weeks needed for a detailed NMR characterization, in the presence 
of high (> 100 mM) concentrations of MgCl2. 
 Due to the problems associated with Mg2+, we carried out an NMR titration using 
CaCl2 as an alternative metal.  Superimposed 1H-15N spectra of apo and Ca2+-bound 
Sma0114 are shown in Figure 3-6A.  In contrast to Mg2+ which has a Kd of 75 mM 
(Figure 3-6B), Sma0114 binds Ca2+ with a  ~1 mM Kd, and saturation is achieved at 1.5 
mM concentrations of CaCl2 (Figure 3-6C).  Residues that show the greatest chemical 
shift changes upon addition of Ca2+ are indicated with boxes in Figure 3-6A, and for the 
most part cluster to the active site.  
 Figure 3-7 shows the chemical shift perturbations observed in 1H-15N HSQC 
spectra of Sma0114 due to addition of CaCl2 (Figure 3-7A) and MgCl2 (Figure 3-7B). 
The unusually large concentration of MgCl2 necessary to achieve saturation induces non-
specific binding to acidic Asp and Glu residues as illustrated by the large number of the 
chemical shift perturbations and line broadening effects observed (Figure 3-7B). By 
contrast, with CaCl2 perturbations are mostly restricted to the active site of the enzyme 
(Figure 3-7A). Some residues become broadened rather than experiencing chemical shift 
changes upon addition of CaCl2 or MgCl2, and these are indicated with arrows in Figure 
3-7. They include Glu17, which is one of the ligands for Ca2+, and Lys105, which is part 
of the active site.  Although most studies of metal-bound receiver domains have used 
Mg2+, Ca2+ was used for structural studies of Spo0A and PhoP (45, 46).  
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Figure 3-6 Metal-binding of Sma0114 followed by NMR spectroscopy.  (A) 
Superposition of 1H-15N-HSQC spectra for the apo (black) and Ca2+-bound forms of 
Sma0114 (pink). Active site residues that show the largest chemical shift perturbations 
and are indicated with green boxes. Titration curves for residues as a function of 
increasing MgCl2 (B) or CaCl2 (C) concentrations. Please note the different scaling of the 
x-axis in (B) and (C). Errors in chemical shift differences estimated from the digital 
resolution of the spectra were 0.02 ppm for (B) and (C). 
  33 
  
Figure 3-7  Perturbations of Sma0114 1H-15N resonances due to metal-binding.  Bar 
graphs show composite HN and N chemical shift changes (ΔHN + 0.1(ΔN)) that occur in 
the presence of 1.5 mM CaCl2 (A) or 150 mM MgCl2 (B).  Residues in boxes indicate 
amino acids that experience large chemical shift perturbations upon metal binding.  
Arrows represent residues that broaden beyond detection in the presence of the metals. 
Errors in the composite chemical shift changes estimated from the digital resolution of 
the spectra were 0.03 ppm. 
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Discussion 
 Several groups have characterized the inactive and active conformations of 
receiver domains (11, 39, 44).  Understanding the structural features of these enzymes 
has provided a wealth of insight into their functions. The Sma0114 receiver domain, 
which may be prototypical of receiver domains associated with HWE-kinases, has a 
conserved active site but shows substantial differences in the 455 face, which is used to 
propagate signal transduction intracellularly.  
The structural and dynamic differences in the 455 face of Sma0114 suggest that 
this enzyme has an altered recognition interface for binding to downstream effectors. The 
PFxFATGY motif that is specific to receiver domains associated with HWE-kinases, 
forms strand β4 in the Sma0114 structure (Pro81-Thr86) and the rigid part of the 
following loop (Gly87 and Tyr88). The last residue in the PFxFATGY motif demarcates 
the start of the Tyr88-Leu93 segment, which replaces helix α4 in Sma0114, and shows 
low S2 order parameters consistent with a dynamically disordered region.  The only other 
receiver domain for which S2 order parameters have been described is the inactive form 
of Spo0F (19).  In the case of Spo0F, it was shown that except for the chain termini, the 
protein is rigid on the ps-ns timescale.  In typical receiver domains, helix α4 is a key 
element of the 455 face that undergoes concerted structural rearrangements following 
phosphorylation to form a new binding surface for downstream effector proteins (11, 40).  
Not only is helix α4 missing in Sma0114 but secondary structure prediction analysis 
suggests that the absence of helix α4, or more rarely helix α5, is a conserved feature of 
HWE-associated receiver domains.  A possible role for flexibility in the segment 
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corresponding to helix α4 is to allow binding of downstream effectors through an 
induced fit mechanism, thereby controlling the specificity of molecular association. 
Residues Pro81 through Gly87 of the PFxFATGY motif, which form strand β4 
and the beginning of the following loop, while rigid on the ps-ns timescale have raised 
R2ex contributions consistent with dynamics on the µs-ms timescale.  The exchange 
contributions to R2 relaxation for these sites, suggest that they experience the dynamic 
conformational equilibrium between the inactive and active substates of the enzyme that 
is a hallmark of receiver domains (4, 39). The PFxFATGY sequence houses the 
conserved Thr86 of the Y-T coupling mechanism. The partner aromatic residue for Y-T 
coupling in Sma0114 is replaced by Leu103. In a previous study of the receiver domain 
CheY, it was shown that the β4/α4 loop and the N-terminal portion of helix α4 constitute 
the binding site for downstream effectors (47).  Because part of the PFxFATGY motif in 
Sma0114 occupies the same position in the structure as the β4/α4 loop region in CheY, it 
is likely that Sma0114 has a similarly reduced binding site for downstream effectors. We 
initially thought that the PFxFATGY sequence motif in Sma0114, may thus substitute or 
circumvent the Y-T coupling mechanism typically used in receiver domains. NMR 
analysis of the activated enzyme was necessary to explore this hypothesis in Chapter 4. 
In spite of the differences in the 455 face, Sma0114 retains the ability to bind 
divalent metal ions needed for activation.  The residues in Sma0114 that experience the 
largest chemical shift perturbations with increasing metal concentrations are consistent 
with the binding site predicted based on sequence homology to other receiver domains 
(Figure 3-6).   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                 Reprinted from Sheftic et al. (2013) (48) 
      I performed all experiments 
 
Chapter Four. Characterization of Activated Sma0114 
 
 
Abstract  
 Sma0114 is the first structurally-characterized representative from the family of 
receiver domains that are substrates for HWE-kinases. Presented here is the NMR 
structure of Sma0114 bound by Ca2+ and BeF3
-, a phosphate analog that stabilizes the 
activated state. Differences between the NMR structures of the inactive and activated 
states occur in helix α1, the active site loop that connects strand β3 and helix α3, and in 
the segment from strand β5 to helix α5 of the 455 face. In Sma0114 the structural 
changes accompanying activation result in a more negatively charged surface for the 455 
face. Coupling between the 455 face and active site phosphorylation is usually mediated 
through Y-T coupling. NMR analysis indicates that Sma0114 lacks Y-T coupling, and 
that communication between the active site and the 455 face is achieved through a 
conserved lysine residue that stabilizes the acyl phosphate in receiver domains. 15N- 
NMR relaxation experiments were used to investigate the backbone dynamics of the 
Sma0114 the binary Sma0114•Ca2+ complex, and the ternary Sma0114•Ca
2+•BeF3
- 
complex to complement the analysis of the apo protein. The loss of entropy due to ligand 
binding at the active site is compensated by increased flexibility in the 455 face. The 
dynamic character of the 455 face in Sma0114, which results in part from the 
replacement of helix α4 by a flexible loop, may facilitate induced-fit recognition of target 
molecules. 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Introduction  
 In order to gain insight into the changes in Sma0114 induced by activation we 
solved the NMR structure of the enzyme in the activated state. Due to the fact that the 
lifetimes of acyl phosphates (~ 30 min) are too short to allow detailed NMR studies, we 
used the phosphate mimetic beryllium trifluoride (BeF3
-) to stabilize the activated state, 
as has been done for other structural studies of receiver domains (49, 50). The structures 
of inactive and activated Sma0114 were analyzed for key differences that could 
communicate the phosphorylation state of the receiver domain from the active site to the 
455 face of the protein. We compared the conformational changes accompanying 
activation of Sma0114 to three homologous single-domain receiver domains, to see what 
features are conserved. Complementary 15N relaxation experiments were used to 
investigate how the dynamics of Sma0114 are affected by binding Ca2+, and by activation 
with Ca2+ and BeF3
-. 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Results 
NMR Structure of Activated Sma0114 
 Backbone (Cα, N, C') traces for the 26 lowest energy NMR structures of the 
Sma0114•Ca2+•BeF3
-
 ternary complex are shown in Figure 4-1A.  Statistics pertaining to 
the quality of the NMR structures are given in Table 4-1. The precision of the activated 
NMR structure over elements of regular secondary structure is 0.71 Å, slightly better than 
the 0.86 Å precision of the inactive state (31).  Other measures of the quality of the 
structure including the Procheck Z-score, RMS deviations from ideal geometry, and 
average residual NOE violations are also slightly better for the activated than inactive 
structure (31). 
 A cartoon showing the α4/β5 Rossmann fold topology of the activated structure is 
shown in Figure 4-1B.  As previously described for the structure of the inactive state in 
Chapter 3, Sma0114 differs from typical receiver domains in having the fourth α-helix of 
the 455 face replaced by a flexible loop. Interestingly, the fourth helix is also absent in 
the structure of the activated state (Figure 4-1B). Thus binding of Ca2+ and BeF3
- does 
not induce folding of the fourth α-helix.   
 Figure 4-1C shows the active site, and key residues that interact with the Ca2+ and 
Be3F
- ions. The three residues Glu15, Asp16, and Glu17 in the loop between strand β1 
and helix α1 (Lβ1α1) each have one oxygen within bonding distance of the Ca
2+ ion (2.1, 
2.1, and 2.4 Å). The Ca2+ ion is within bonding distance of two fluorine atoms from the 
BeF3
- molecule (1.8 and 2.1 Å).  
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Figure 4-1 NMR Structure of the ternary Sma0114•Ca2+•BeF3- complex. (A) Stereo-
diagram of the 26 lowest energy NMR structures superimposed over regular main-chain 
secondary structure elements: β1 (10-15), α1 (18-31), β2 (34-39), α2 (42-51), β3 (55-60), 
α3 (70-78), β4 (81-86), β5 (102-104), α5 (110-118).  (B) Backbone cartoon of the NMR 
structure closest to the ensemble mean.  (C) Sidechains that participate in ligand binding 
at the active site of Sma0114 and Thr86.  The Ca2+ ion is shown in purple and the BeF3
- 
molecule in pink and cyan. 
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Table 4-1: Statistics for the 26 Lowest Energy NMR Structures of 
Sma0114•Ca2+•BeF3- 
NMR restraints (total)     1791     
Distance (total)      1644 
 Intraresidue NOEs       472  
 Sequential NOEs        479 
 Short range NOEs (1< |i-j| < 5)      136 
 Long range NOEs (5 ≤ |i-j|)      495 
 Hydrogen bonds (31x2)          62 
Dihedral (ϕ 70, ψ 61, χ1 16)        147 
Residual restraint violations 
NOE (Å)a       0.033 ± 0.0004 
Dihedral (°)b       0.587 ± 0.075 
RMS deviations from ideal geometry 
Bonds (Å)       0.0037 ± 0.0002  
Angles (°)       0.724 ± 0.004 
Improper torsions (°)      0.560 ± 0.007 
van der Waals energy (kcal/mol)c    87.85 ± 1.75 
Lennard-Jones energy (kcal/mol)d    -85.42 ± 6.33 
ProcheckNMR Z-scoree     -2.11 
Ramachandran statistics for all residuese (and excluding loopsf) 
 most favored (%)     58.8 (58.2) 
 allowed (%)      29.6 (36.8) 
 generously allowed (%)      7.5   (4.9) 
 disallowed  (%)       4.1   (0.0) 
Coordinate RMS deviations (Å) 
NMR ensemble to average      Cα, C, N  All Heavy 
 Entire domain (110 residues)g    0.88  1.34 
 Excluding loops (70 residues)f   0.71  1.19 
NMR model to inactive model 
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 Entire domain (110 residues)g   1.91  2.70 
 Excluding loops (70 residues)f    1.66  2.32 
 
 
_________________________________________________________________________ 
 
 
a Structures have no NOE violations greater than 0.3 Å 
b Structures have no dihedral violations greater than 5° 
c Evdw was calculated using the X-PLOR Frepel function (34) with van der Waals interactions and 
atomic radii set to 0.8 times their CHARMM (35) values.  
d EL-J was calculated using the CHARMM empirical energy function (35). 
e ProcheckNMR used via Protein Structure Validation Suite (PSVS) (36).  
f  Only residues in regular secondary structure (10-15, 18-31, 34-39, 42-51, 55-60, 70-78, 81-86, 
102-104, 110-118). 
g Excluding N-terminus (residues 1-9) and C-terminus (residues 119-123). 
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The third fluorine atom does not appear to form any bonding interactions. The fluorine 
atom closest to the Ca2+ is 2.6 Å away from the Nz atom of Lys105. The positively 
charged Nz atom of Lys105 may also be involved in an electrostatic interaction with the 
OE2 atom of Glu15, with the two separated by 3.9 Å. The Be atom of BeF3- is bonded to 
the OD2 atom of Asp60 (2.0 Å). 
 
Conformational Changes Induced by the Activation of Sma0114   
 The structures of Sma0114 in the inactive and activated states, modeled by the 
Sma0114•Ca2+•BeF3
- ternary complex, are shown superimposed in Figure 4-2A. A plot 
of the Cα RMSD after superimposition of the two structures is shown in Figure 4-2B. 
The mean RMSD over all residues is 1.91Å (Table 4-1). Regions of the protein that show 
larger differences than the mean RMSD are colored in pink and labeled (Figure 4-2A).  
 The largest difference is seen for the loop between strand β3 and helix α3 (Lβ3α3) 
that partially covers the active site in the inactive structure but is in an open conformation 
in the activated state. As expected, differences are seen in the 455 face. The C-terminus 
of strand β5 becomes shorter by one residue, Lys105, which becomes part of Lβ5α5 in the 
activated state. The C-terminus of strand β5 moves away from the core of the structure by 
about 1.0-1.5 Å in the activated state, and undergoes a twist of about 30 degrees to align 
better with strand β4.  In the activated state, helix α5 undergoes a tilt of about 10-30 
degrees to make it less parallel with the β-strands compared to the inactive structure.   
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Figure 4-2 Comparison of the inactive and activated NMR structures of Sma0114.  (A) 
Stereo-diagram showing the least-squares superimposition of the inactive (grey) and 
activated (cyan) structures. Residues with the largest RMS differences between the two 
structures are indicated in pink on the activated structure. (B) Bar plot of Cα RMSD 
values between the inactive and activated structures.  Labels indicate the largest 
differences between the two structures, with green and orange labels indicating segments 
from the active site and 455 face, respectively.  
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The helix also undergoes translational displacements in the activated state, including a 
shift of 1.0 Å towards the top of the molecule (defined by the arrows indicating the C-
termini of the β-strands in Figure 4-2A) and a move of about 1.5 Å closer to the core of 
structure. Outside of the 455 face, there are changes in α-helices 1 and 2 (Figure 4-2).  
Helix α1 undergoes a bend in the activated structure which brings the last two turns about 
1-2 Å closer to helix α5 and to the core of the structure. Similarly, helix α2 experiences a 
10-20 degree axis tilt in the activated state, that brings the C-terminus of the α-helix 
closer to the β-sheet core of the protein. Overall, the movement of α-helices 1 and 5 
towards each other and the protein core, make the activated state structure slightly more 
compact than the inactivated structure. The radii of gyration calculated from the 
structures are 14.2 Å for the inactive and 13.8 Å for the activated states.  
  
Comparison to Other Receiver Domains 
 To investigate the extent to which the changes associated with activation of 
Sma0114 are conserved in other receiver domains, we looked at three single-domain 
response regulators NtrC, CheY and Spo0F, shown in Figure 4-3.  As in Figure 4-2, the 
largest changes between the inactive and activated states are highlighted in pink on the 
activated structures (Figure 4-3A) and bar graphs are used to summarize Cα RMSDs 
(Figure 4-3B). The analysis shows that the conformational changes induced by the 
activation of receiver domains can be quite variable. 
 In NtrC and CheY, conformational changes occur primarily along the 455 face of 
the activated enzymes, particularly for helices α4 and α5.  
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Figure 4-3 Structurally homologous single domain response regulators.  (A) 
Superimposition of inactive (grey) and activated (cyan) structures of NtrC (PDB codes 
1NTR and 1KRX), CheY (PDB codes 5CHT and 1DJM) and Spo0F (PDB codes 1NAT 
and 1PUX). Regions that show the largest differences upon activation are colored in pink 
on the activated structures. (B) Corresponding Cα RMSD plots showing the largest 
differences between the inactive and activated structures.  
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Despite the absence of helix α4 in Sma0114 we do observe changes in the structure of 
the β5 - α5 segment (Figure 4-2). The Spo0F receiver domain shows only small 
differences for the 455 face, with the majority of structural changes occurring for the first 
three α-helices outside of the 455 face (Figure 4-3) (38, 39).  Like other single domain 
response regulators shown in Figure 4-3, Sma0114 (Figure 4-2) shows structural changes 
for helix α1 between the inactive and active states. This suggests that helix α1 could 
participate together with the 455 face in binding downstream effectors, or alternatively 
that it may be important in the transition to an activated state. Indeed, mutagenesis 
experiments indicate that helix α1 of receiver domains plays a role in determining the 
kinase specificity of receiver domains (51). The types of structural changes that occur 
upon activation appear to follow similar trends. As in Sma0114, activation of the NtrC, 
CheY, and Spo0F single domain receiver domains brings the α-helices closer to the β-
sheet core of the structures (Figure 4-3A).  Another conserved theme is that helices α1 
and α5 move closer together in the activated states (Figure 4-3A). 
 The largest changes observed between the inactive and activated states are in the 
active site loops, particularly Lβ3α3 following the phosphorylation site (Figure 4-3B).  In 
all three structures, except CheY, where the differences are relatively small, Lβ3α3 moves 
away from the active site in the activated state (Figure 4-3A). The open conformation of 
Lβ3α3 was seen for NtrC (11) but the authors noted that the precision of that region in the 
inactive structure precluded additional analysis. In Sma0114 the average RMSD for 
residues comprising Lβ3α3 (Val61-Glu66) between the inactive and activated states is 3.2 
Å. These RMSD values are much larger than the internal precisions of the structures 
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(RMSDs of 0.94 for the inactive (Table 3-1)  and 0.88 for the activated structure (Table 
4-1)). That the displacement of Lβ3α3 appears to be a conserved theme for the activated 
states of receiver domains suggests that its open conformation plays an important role in 
activation.   
 
Sidechain Changes Accompanying Activation   
  An interesting question is how the phosphorylation state of the activated enzyme 
is communicated to the 455 face in order to achieve the conformational transition that 
prepares the receiver domain to bind its cognate effector proteins. Moreover, since 
binding to partner molecules is likely to involve surface interactions, it is important to 
characterize how activation affects the surface of the receiver domain.  
 In typical receiver domains, active site phosphorylation propagates structural 
changes to the 455 face through Y-T coupling (1).  Upon phosphorylation of a conserved 
aspartate, a hydrogen bond forms via a Thr/Ser sidechain hydroxyl with the phosphate.  
The displacement of a Thr/Ser leaves an internal cavity that is filled by the reorientation 
of an Tyr/Phe residue from the surface to the interior of the structure (1). Thus, the 
coupled rearrangement is the conformational change linking the active site and output 
455 face. In Sma0114 the conserved threonine corresponds to Thr86. As shown in Figure 
4-4A, Thr86 in strand β4 is in a nearly identical position before and after activation. The 
hydroxyl oxygen of Thr86 is 7.0 Å away from the closest fluorine atom in BeF3
-, and is 
therefore too far to form a bond. Leu103 in strand β5 replaces the partner aromatic 
residue for the Y-T coupling mechanism commonly seen in receiver domains.  
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Figure 4- 4 Stereo-diagrams comparing selected sidechains between the inactive and 
activated states of Sma0114. (A) The sidechain conformations of PFxFATGY motif  
residues that show little change. (B) Sidechains that undergo large structural changes 
between the inactive and activated conformations include Asp64 at the active site, and 
Leu103, Lys105, Phe107 and Glu111 in the 455 face of the domain. The backbone trace 
structure is shown for the activated state (gray).  Sidechains from the inactive structure 
are shown with yellow carbons while those from the activated state are shown with green 
carbons. 
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The sidechain of Leu103 does undergo a reorientation upon activation but from the 
interior of the protein to the surface, the opposite of what is seen for the corresponding 
aromatic residue in typical receiver domains. These observations suggest that like the 
CheY2 receiver domain (37), Sma0114 lacks the Y-T coupling mechanism. 
 Based on the structure of the inactive protein, we proposed that the Y-T coupling 
mechanism in Sma0114 may be substituted by the PFxFATGY sequence motif. This 
sequence motif is highly conserved in the subfamily of receiver domains that are 
substrates for HWE-kinases. As shown in Figure 4-4A, the PFxFATGY sequence motif, 
which includes Thr86 and forms strand β4 of the Sma0114 structure, shows only minor 
structural differences between the inactive and activated protein (also see Figure 4-2B). 
Of the residues in the PFxFATGY motif, Thr86 comes closest to the BeF3
- molecule, 
through its Hα proton, which is 4.1 Å away. Given that there are no major structural 
changes in the PFxFATGY motif between the inactive and activated structure it seems 
unlikely that this motif plays a role in activation. Due to it's conservation in the HWE-
kinase associated subfamily it is possible that the PFxFATGY motif has a role in kinase 
binding or is part of the modified surface of Sma0114 used to bind effector molecules.   
 Figure 4-4B shows the sidechains that experience the largest changes between the 
inactive and activated structures. Lys105 is one of the residues with the greatest 
perturbation. In the inactive state Lys105 forms a salt-bridge with Asp109 on the 455 
surface of the domain. This salt bridge is broken in the activated structure, where the 
Lys105 sidechain enters the interior of the protein to bind BeF3
-. The repositioning of 
Lys105 to the interior of the domain is accompanied by the displacement of Leu103 in 
strand β5 from the interior towards the surface of the structure. The cavity left by the 
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displacement of Leu103 is filled by Lys105 and by the aromatic ring of Phe107 from 
loop Lβ5α5. The movement of Phe107 leaves room for Glu111 to switch from a position 
on the surface exposed side of helix α5 to one that bridges the gap between helices α5 
and α1.  Part of what may contribute to bringing helix α1 closer to the β-sheet core of the 
protein is an electrostatic interaction between His33 NE2 and Asp55 OD1, which are 4.3 
Å apart in the activated state versus 8.2 Å apart in the inactive structure. 
 Outside of the 455 face, large changes in sidechain positions are found at the 
active site. These include Glu17, which moves from a surface position towards the 
interior of the structure to act as a ligand for the Ca2+ ion. Large changes are also seen for 
the entire loop Lβ3α3, spanning residues Val61-Glu66, which moves away from the 
active site to an 'open' conformation in the activated structure (Figure 4-4B). The 
displacement of Lβ3α3 in the activated structure may be due to steric occlusion from the 
BeF3
- molecule, Ca2+ ion, and the ligating residues from the protein that move into the 
active site. Electrostatic repulsion between Asp64 at the center of this loop and the high 
density of negatively charged groups in the active site (Glu15, Asp16, Glu17, Asp60) 
may also contribute to the displacement of the loop. 
 The sidechain changes accompanying activation of Sma0114 lead to changes in 
the surface properties of the 455 face, as shown in Figure 4-5. Sma0114 has a 
predominantly anionic character with a pI of 4.5, due to an excess of 21 acidic over 11 
basic residues. Most of the surface of Sma0114 is negatively charged, except for a 
positively charged patch corresponding to the exposed sides of helices α2 and α3.  
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Figure 4-5 Electrostatic potential surface for the 455 face in (A) the inactive domain and 
(B) the activated domain.  Red and blue correspond to negative and positive electrostatic 
potentials, respectively. The positions of Asp64, Asp109, and helix α1 are indicated on 
the surfaces.  Electrostatic potentials were calculated with the APBS server (52). 
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This unusual charge distribution is unique to Sma0114, and is not a feature shared with 
other receiver domains. The views in Figure 4-5 show the 455 face in front. The ridge to 
the right below the 455 face, is due to helix α1. The interface between helices α1 and α5 
that closes the Rossmann fold structure has a high density of negatively charged residues. 
Activation of Sma0114 appears to increase the negative character of the 455 surface. This 
is particularly evident near Asp109, which is labeled in Figure 4-5. In the inactive state 
(Figure 4-5A) the charge on Asp109 is complemented by a salt bridge with Lys105. 
Upon activation Lys105 switches to the interior of the protein to bind BeF3
-, leaving the 
negative charge on Asp109 exposed (Figure 4-5B). Other more subtle changes such as 
partial burial of the basic residues Lys91 and Arg96 also contribute to the display of a 
more negatively charged 455 surface in the activated state (Figure 4-5B). 
 
  Effects of Ca2+ and BeF3- Binding on Backbone Dynamics   
 Figure 4-6 shows S2 order parameters, that describe the amplitudes of backbone 
HN motions on the ps-ns timescale, for inactive Sma0114 (Figure 4-6A) , the 
Sma0114•Ca2+ binary complex (Figure 4-6B), and the activated Sma0114•Ca2+•BeF3
- 
ternary complex (Figure 4-6C).  The active site loops, Lβ1α1 and Lβ3α3 that contribute 
ligands to Ca2+ and BeF3
-, show average S2 order parameters. The lack of ps-ns motions 
in these loops indicate a lack of dynamic flexibility for these regions in the inactive state 
(Figure 4-6A). As we only have data on backbone dynamics, this does not exclude 
increased sidechain flexibility for these residues. In the inactive protein (Figure 4-6A), 
low S2 order parameters indicative of backbone flexibility occur at the chain termini and 
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in the portion of loop Lβ4β5 that corresponds to helix α4. The chain termini, and residues 
(Lys91, Gly92, Leu93) in the loop retain low S2 terms in the all three states. Thus the 
region corresponding to helix α4 remains unfolded in the metal-bound and activated 
states.   
 Backbone flexibility is increased at a number of sites in the Sma0114•Ca2+ binary 
complex (Figure 4-6B) compared to the inactive protein (Figure 4-6A). This includes 
residues Met19 and Leu24 following the metal binding site in helix α1. In the 455 face 
increased mobility is seen for residues Leu102 in strand β5 and Val115-Val117 at the end 
of helix α5. The enhanced backbone dynamics in regions of the protein remote from the 
binding site, suggest an entropy-compensated binding mechanism (53-56), where the 
ordering of the Ca2+-binding site is offset by increased mobility in other parts of the 
molecule.  
 Data on the backbone dynamics for the activated state, stabilized by the binding 
of Ca2+ and BeF3
- are shown in Figure 4-6C. The S2 order parameters of the inactive and 
activated protein are mapped on their corresponding structures in Figure 7. Mobility in 
helix α1 is reduced in the activated state (Figure 4-6C) compared to the Ca2+-bound state 
(Figure 4-6B); except for residues Ile20 and Met22 immediately following the Ca2+ 
binding loop, which show intermediate order parameters (Figure 4-7). Like the Ca2+-
bound state, the activated state shows flexibility for residues in the 455 face, although 
there are some subtle differences compared to the former. In the activated state residues 
Thr104-Phe107 in loop Lβ5α5 show raised mobility whereas in the Ca
2+-bound state 
residue Leu102 in strand β5 is mobile (Figure 4-6B, 4-6C).  
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Figure 4-6  S2 order parameters for Sma0114 in the apo state (A) the Ca2+ binary 
complex (B) and the Ca2+•BeF3- ternary complex (C). The correlation times for each state 
were 5.6 ns for A, 5.9 ns for B, and 5.7 ns for C. A secondary structure diagram with α-
helices represented by cylinders and β-sheets by arrows is shown in (A). Segments of the 
protein that show low S2 order parameters are labeled in each panel. 
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Interestingly, the residue with the highest backbone mobility in loop Lβ5α5 of the 
activated state is Lys105, whose sidechain binds BeF3
-. Like the Ca2+-bound protein, the 
activated state exhibits low S2 order parameters for residues Val115-Val117 at the C-
terminal end of helix α5. 
 Figure 4-8 shows R2ex line-broadening contributions for the three states obtained 
from Model-Free calculations (32, 42, 57). In both the apo protein (Figure 4-8A) and in 
the Ca2+-bound state (Figure 4-8B) there are four regions that have large R2ex terms 
indicative of conformational exchange on the µs-ms timescale. These are (I) the metal 
binding loop (Lβ1α1), (II) Lβ3α3 following the site of phosphorylation Asp60, (III) the C-
terminal region of strand β4, and (IV) the β5-Lβ5α5 segment that holds Lys105, which 
stabilizes the acyl-phosphate moiety. R2ex contributions for these regions have been 
described in other receiver domains, and have been attributed to a dynamic equilibrium 
between the inactive and active conformations (6, 20). Consistent with previous work on 
other receiver domains (6, 20), the R2ex terms for regions I-IV in Sma0114 decrease as 
the equilibrium is shifted in favor of the activated state, by binding Ca2+ and BeF3
- 
(Figure 4-8C). The large number of R2ex terms between 0 and 5 Hz for the activated state 
are an artifact of lower precision 15N relaxation data. The relatively high salt 
concentration of 30 mM NaF, needed to generate BeF3
- in the sample, reduces the 
sensitivity of the relaxation data.   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Figure 4-7 S2 Order parameters mapped onto the NMR structures of (A) inactive and (B) 
activated Sma0114. The data are from Fig. 4-6A and 4-6C. The S2 values are represented 
with a ROYGBIV seven-color gradient with red being the most flexible 0.00 ≤ S2 ≤ 0.14 
and violet the least flexible 0.84 < S2 ≤ 1.00. In the inactive structure, flexibility is 
predominantly associated with the loop Lβ4β5 which replaces the canonical receiver 
domain fold helix α4 in Sma0114 (A). In the activated domain the loop Lβ4β5 remains 
flexible and additional flexibility is seen for residues in helix α1, loop Lβ5α5, and helix α5, 
with the latter two belonging to the 455 face of the domain. Residues experiencing the 
greatest change in flexibility, Thr104, Lys105, Val115 and Leu116, are labeled on the 
activated structure. The phosphorylation site (Asp60) is labeled in (A) and (B). 
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Figure 4-8  R2ex contributions for (A) apo-Sma0114 (B) the Sma0114•Ca2+ binary 
complex and (C) the Sma0114•Ca2+•BeF3- ternary complex. The secondary structure is 
shown in (A). The apo domain (A) shows four regions with raised R2ex values: (I) the 
metal-binding site, (II) the phosphorylation site, (III) the C-terminal end of strand β4, and 
(IV) the junction between stand β5 and helix α5. The R2ex contributions persist when 
Ca2+ is bound (B) but are suppressed in the Sma0114•Ca2+•BeF3
- ternary complex. 
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Discussion 
 Phosphorylation causes a conformational switch that enables a receiver domain to 
bind downstream target molecules (5). The duration of the output response, which can 
range from seconds to hours, is regulated by the lifetime of the acyl phosphate linkage 
that induces the conformational transition to the activated state. In the current study we 
stabilized the activated state of Sma0114 by binding Ca2+ and the phosphate analog BeF3
-
, as has been done in other studies of receiver domains (37, 50) due to the limited lifetime 
of the acyl phosphate. In the present work we describe the NMR structure and dynamics 
of the activated form of Sma0114 to provide a more complete picture of the activation 
mechanism of this enzyme that is prototypical for the family of receiver domains 
activated by HWE-kinases.    
 A large difference between the structures of inactive and activated Sma0114 
occurs in the loop Lβ3α3. In the inactive state this loop folds over the active site, partially 
occluding it (Figure 4-2A). Our active state structure shows that Lβ3α3 retains an open 
conformation in the activated state that leaves the active site more exposed compared to 
the inactive state (Figure 4-2A). One possible advantage of having Lβ3α3 displaced from 
the active site is that it could facilitate a water molecule entering the active site to 
perform hydrolysis of the phosphate group. The release of the phosphate-leaving group 
after the autophosphatase activity of Sma0114 would also be facilitated by the open 
Lβ3α3 that exposes the phosphorylation site Asp60. As such, loop Lβ3α3 could participate 
in determining the lifetime of the activated state before the enzyme switches back to its 
inactive state.  
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 A key question in the structural biology of receiver domains is how 
phosphorylation of the conserved aspartate induces the conformational switch needed to 
bind downstream effector molecules. Typically the initial conformational switch occurs 
through Y-T coupling when a threonine at the C-terminal end of strand β4 repositions to 
hydrogen bond to the phosphate. The movement of the threonine allows the reorientation 
of an aromatic residue (typically a tyrosine) in strand β5 from the surface of the 455 face 
to the interior of the protein, thus propagating conformational changes from the active 
site to the 455 face (1). In Sma0114 Thr86, corresponding to the threonine in Y-T 
coupling, is too far from the active site to hydrogen bond to the phosphate and shows 
little structural difference between the inactive and activated states (Figure 4-4A). The 
conserved aromatic residue is replaced by Leu103, which switches from the inside to the 
outside of the Sma0114 structure on activation, the opposite of what is seen for the 
aromatic residue in classical Y-T coupling. Receiver domains that are substrates for 
HWE-kinases have a highly conserved PFxFATGY sequence motif that encompasses the 
threonine of Y-T coupling, Thr86 in Sma0114, and we proposed that it could be used as 
an alternative for communication between the active site and the 455 face (31). The NMR 
structure of the activated state, however, shows that residues of the PFxFATGY motif in 
strand β4 retain similar conformations to those seen in the inactive state, and are too far 
away from the active site to substitute for the Y-T coupling mechanism (Figure 4-4A). 
We can conclude that Y-T coupling is eliminated in Sma0114 and the conserved 
PFxFATGY motif appears not to be an alternative conduit of communication between the 
active site and output response face.  
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 The only interaction between the 455 face and the active site that to our 
knowledge is conserved in all receiver domains, is that between Lys105 in loop Lβ5α5 
and the phosphate or BeF3
- ion. In the activated state of Sma0114, the repositioning of 
Lys105 to bind BeF3
- is accompanied by a number of changes that affect the 455 face. 
These include a displacement of Leu103 in strand β5 from the interior to the surface of 
the protein, and movements of Phe107 and Glu111 towards the interior of the protein that 
bring helix α5 closer to the β-sheet core and to helix α1 in the activated structure. 
Although the role of Lys105 has traditionally been viewed as stabilizing the acyl 
phosphate (4), it also seems the most likely candidate to effectuate the communication 
between the active site and 455 face of Sma0114. 
 Because different receiver domains recognize a variety of downstream targets the 
structural changes accompanying activation are variable.  In most receiver domains the 
largest changes induced by activation occur on the 455 face (Figure 4-3), however, this is 
not always the case. Activation of the bacterial sporulation factor Spo0F leaves the 455 
face relatively unchanged. The largest structural changes occur in helix α1 (Figure 4-3), 
and these have been shown to play important roles in protein-protein interactions with the 
downstream targets of Spo0F (39).  Activation of Sma0114 leads to structural changes in 
strand β5 and helix α5 of the 455 face (Figure 4-2), with the important difference that 
helix α4 of the typical receiver domain fold is replaced by a flexible loop. Additional 
changes extend to helix α1, which is also perturbed in the activated state of the three 
receiver domains NtrC, CheY, and Spo0F (Figure 4-3). We cannot identify if the 
rearrangement of helix α1 in Sma0114 occurs after Ca2+ binding or BeF3- binding, 
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although the perturbed conformation is maintained in the fully activated enzyme. 
Therefore, helix α1 may have a role in priming the enzyme for phosphorylation or 
participate in the output response by binding effectors in the fully activated state. 
Changes in secondary structure elements accompanying activation must lead to changes 
in the surfaces of receiver domains that enable them to bind their downstream target 
molecules. In the case of Sma0114, the sidechain rearrangements that accompany 
activation give the 455 face a more negatively charged character (Figure 4-5) that could 
be used to select positively charged target molecules. 
 Receiver domain dynamics on slow µs-ms timescales have been investigated 
using relaxation dispersion methods (6, 20, 58). These studies showed that the inactive 
and activated conformations exist in a dynamic equilibrium, that is shifted in favor of the 
activated state when the active site binds ligands (6). Our results for Sma0114 are 
consistent with this two-state allosteric mechanism of activation. The apo (Figure 4-8A) 
and Ca2+-bound enzyme (Figure 4-8B) exhibit R2ex line-broadening contributions for 
NMR signals from residues in the active site and 455 face. The R2ex contributions are 
suppressed in the Sma0114•Ca2+•BeF3
- ternary complex, where the population of the 
activated state dominates (Figure 4-8C).  
 By contrast, there have been few studies of receiver domain dynamics on the fast 
ps-ns timescales accessible by 15N relaxation measurements. Spo0F was characterized 
only in the apo-state where dynamics on the ps-ns timescale were shown to be constant 
except at the chain termini (19).  For NtrC, ps-ns dynamics were characterized for both 
the inactive and activated forms of the enzyme, and were shown to be constant except at 
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the chain termini (6). In the case of Sma0114 we characterized ps-ns dynamics for three 
forms of the protein: the apo-state, the Ca2+-bound state, and the activated state (Figure 4-
6). Both the Sma0114•Ca2+ binary complex (Figure 4-6B) and the Sma0114•Ca2+•BeF3
- 
ternary complex (Figure 4-6C) show an increase in the number of residues exhibiting 
flexibility on the ps-ns timescale compared to the apo-protein (Figure 4-6A). These 
results suggest an entropy-compensated binding mechanism for the BeF3
- phosphate 
analog, where the decrease in entropy due to ligand binding in the active site is 
compensated by increased dynamics in other parts of the structure. Entropy-compensated 
binding was first hypothesized in 1963 for insulin dimerization (53). The mechanism has 
since been supported by NMR relaxation studies showing increased dynamics 
accompanying ligand binding in a number of proteins (54, 55, 59), including the enzymes 
MutT (56), stromelysin (60), and topoisomerase I (61).  
 In the case of Sma0114, entropy-compensated binding is likely to be exploited for 
a functional role, as most of the residues that show increased dynamics in the activated 
state are part of the 455 face of the protein. These include residues Thr104-Phe107 in 
strand β5 and loop Lβ5α5 and Val115-Val117 in helix α5. The mobile loop, (Gly89-
Leu93) that replaces helix α4, together with the above segments give the 455 face in 
Sma0114 a flexible character (Figure 4-7B). Flexibility in the 455 face could be used to 
bind downstream effector proteins through an induced-fit mechanism, initially proposed 
by Dyson and Wright (62, 63). In an induced-fit mechanism, weak interactions with 
diffuse specificity are first formed using the dynamic segments of a binding surface and 
strengthen as the appropriate ligand is drawn closer to the receptor and the complement 
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of correct interactions are formed. The dynamically disordered surface in Sma0114 may 
facilitate binding a range of molecules each having a common molecular shape 
recognized by the 455 face.  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Chapter 5. Materials and Methods 
 
 
Sma0114 Expression and Purification. 
 The sma0114 gene was amplified from S. meliloti strain Rm1021, cloned into the 
pET28(+) plasmid, and transformed into Escherichia coli strain BL21(DE3)pLysS.  Cells 
were grown in 1 liter of M9 medium containing 1.0 g 15N-NH4Cl and/or 3 g of 13C-
glucose supplemented with kanamycin to a final concentration of 25 µg/ml. Following 
incubation at 30°C to mid-log phase, the recombinant His-tagged Sma0114 protein was 
induced by the addition of isopropyl β-D-1 thiogalactopyranoside (IPTG) to a final 
concentration of 0.5 mM.  Cells were harvested 18 hours after induction and lysed by 
sonication in affinity column binding buffer (100 mM Tris-HCl, 0.5 M NaCl, pH 7.4) 
containing lysozyme and 1 mM phenylmethanesulfonyl (PMSF).  The cell debris was 
sedimented and the His6-Sma0114 fusion protein in the supernatant was purified by 
nickel affinity chromatography on a 1 ml HisTrap column.  Following elution, fractions 
containing His6-Sma0114 were pooled and cleaved overnight at 23°C with 10U/ml of 
bovine thrombin.  PMSF was subsequently added to inactivate thrombin, and the 
Sma0114 component was further purified by gel filtration on a Superdex S75 column.  
The fractions eluted from this column were run over a 1 ml HisTrap column to remove 
any uncut His6-Sma0114.  The remaining flow-through containing Sma0114 at > 95% 
purity by SDS-PAGE, was dialyzed extensively against the buffer used for NMR (50 mM 
sodium phosphate pH 6.0).  Following dialysis, samples were concentrated for NMR 
using 10,000 molecular weight cut-off centrifugal filter units.   
The Sma0114 construct used for these studies contains the extra three N-terminal 
residues Gly-Ser-His from the thrombin cleavage site used to purify the protein.  These 
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residues are included in our numbering scheme for the protein, which runs from residues 
Gly1 to Val123 with only residues Met4-Val123 part of the wild type Sma0114 amino 
acid sequence.  We did not detect NMR signals from the amide protons of the extra 
residues Gly1-His3, suggesting they are disordered. 
 
NMR Sample Preparation  
  NMR samples of the inactive enzyme were dissolved in 50 mM sodium phosphate 
pH 6.0 supplemented with 0.02% NaN3 to prevent bacterial growth and 1 mM 
dithiothreitol (DTT) to prevent disulfide formation due to the sole cysteine at position 29 
in the protein. For NMR spectroscopy on the activated enzyme, 15N-Sma0114 and 
15N,13C-Sma0114 samples were dissolved in 50 mM 2-(N-morpholino)ethanesulfonic 
acid (MES), buffered to pH 6.0. MES buffer was used for experiments on the binary 
Sma0114•Ca2+ and ternary Sma0114•Ca2+•BeF3- complexes rather than phosphate, to 
prevent precipitation of Ca2+. Samples had 500 µM concentrations of protein. All NMR 
experiments were done at a temperature of 37°C. NMR metal titrations were performed 
using 15N-labeled samples of Sma0114, over a range of concentrations between 0 and 500 
mM MgCl2. Due to the high 150 mM concentration of MgCl2 needed to saturate the 
enzyme, we also looked at the binding of CaCl2 over a concentration range between 0 and 
10 mM. With CaCl2, saturation of Sma0114 was achieved at a metal ion concentration of 
1.5 mM.  
The Sma0114•Ca2+•BeF3- ternary complex was prepared using the approach of 
Yan, et al. (49). BeF3-, generated in situ from the addition of NaF to BeCl2, mimics the 
acyl phosphate linkages formed by the active site aspartates of receiver domains (11, 39, 
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49, 50). Starting from samples of Sma0114 containing 1.5 mM CaCl2, we added NaF in 
increments of 5 mM and observed no changes in 1H-15N HSQC spectra of the protein up 
to a final concentration of 30 mM NaF. Thus the presence of NaF, which is needed to 
generate BeF3- from BeCl2, does not perturb the structure of Sma0114. We next added 
BeCl2 in 1 mM increments and found that a 5 mM concentration was sufficient to 
saturate the active site, as monitored by the point at which no further chemical shift 
changes were seen in 1H-15N HSQC spectra. Thus the final sample conditions for the 
Sma0114•Ca2+•BeF3- ternary complex were 500 µM Sma0114, 1.5 mM CaCl2, 30 mM 
NaF, and 5 mM BeCl2. 
 
Inactive Sma0114 Nuclear Magnetic Resonance Spectroscopy 
 Samples of 250 µl volumes were taken up Shigemi microcells. Spectra were 
recorded on a Varian INOVA 600 MHz spectrometer equipped with a cryogenic probe.  
The temperature for all experiments was 37°C. NMR assignments were obtained using 
2D and 3D experiments (64) implemented in the Varian Protein Pack.  Starting from the 
2D 1H-15N HSQC spectrum, backbone 1H, 15N and 13C resonances were assigned using 
two redundant sequential walk pathways.  The first used 3D HNCACB, HNCA and 
HN(CO)CA data to establish Cα and Cβ connections across peptide bonds.  The second 
pathway used HNCO and HN(CA)CO experiments to connect C’ carbons across peptide 
bonds. Sidechain assignments were obtained from 3D HCCH-TOCSY, H(CCO)NH, 
C(CO)NH, HNHA, HNHB, 1H-15N TOCSY-HSQC, and 1H-13C HSQC-NOESY data.  
Stereo-specific assignments for methylene protons were based on short mixing time (25 
ms) 2D NOESY, 3D 1H-15N NOESY-HSQC and HNHB experiments as described (65).  
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Aromatic 1H and 13C resonances were obtained from 2D 1H-13C  HSQC, DFQ-COSY and 
TOCSY data.  2D NOESY experiments (150 ms mixing time) using a sample in D2O 
were used to connect aromatic resonances with previously assigned aliphatic resonances.  
Sidechain amide resonances were linked through intra-residue NOEs to previously 
assigned aliphatic protons using 3D 1H-15N NOESY-HSQC data.  DSS was used as an 
internal reference for 1H resonances, and 13C and 15N resonances were referenced 
indirectly (66). Spectra were processed and analyzed using FELIX-NMR and iNMR.  
The limits of secondary structure elements were determined using 3JHNHα - coupling 
constants (67), TALOS chemical shift analysis (29) and hydrogen-deuterium exchange 
data.  
 
Inactive Sma0114 Chemical Shift Assignments  
 1HN, 15N, 13C’, Cα,  Cβ, Hα and Hβ resonances were assigned for 94% of the 
amino acids in Sma0114.  In total, we obtained assignments for 84% of all carbons (90% 
of aliphatic carbons and 65% of aromatic carbons), 84% of all protons (84% aliphatic and 
85% of aromatic protons) and 75% of all nitrogens.  Four of 118 non-proline residues 
were not observed in the 1H-15N HSQC spectrum: Leu108, and residues Gly1-His3 which 
are not part of the wild type sequence but were introduced as part of a thrombin cleavage 
site used in purification of Sma0114. Chemical shift assignments are deposited in the 
Biological Magnetic Resonance Bank (http://www.bmrb.wisc.edu) under accession code 
BMRB-16905.  
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Chemical shifts for the Activated Enzyme 
 The 2D 1H-15N HSQC of the inactive enzyme (Figure 2-2) was used as a 
reference for assigning resonances in the ternary Sma0114Ca2+BeF3- complex.  Having 
complete assignments for the inactive protein (Chapter 2) facilitated NMR assignments 
for the active form since only a subset of resonances undergo changes upon activation. 
Figure 5-1 shows chemical shift changes in 1H-15N HSQC spectra for the Ca2+-bound 
enzyme (A) and the fully activated (Ca2+ and BeF3- bound) enzyme (B).  
 Changes in sidechain chemical shifts for the activated enzyme were determined 
from 13C-HCCH-TOCSY spectra which correlates all side-chain protons with alpha or 
beta protons of individual amino acids while allowing the assignment of sidechain 
carbons (68). Chemical shift assignments for the Sma0114•Ca2+•BeF3- ternary complex 
have been deposited in the BMRB database under accession code 19286. 
 
NMR Structure Determination for Inactive Sma0114  
 3D 15N- and 13C-editted NOESY experiments (64)  were used to obtain NOE-
based distance restraints. Long-range HNCO (69) and deuterium isotope exchange 
experiments were used to identify hydrogen bonds. Restraints for the backbone dihedral 
angles φ and ψ were calculated from the assigned HN, Hα, N, Cα, Cβ and C’ chemical 
shifts using the program TALOS (29). Additional 3D HNHA data were collected to 
check φ dihedral angles.  Side-chain χ1 dihedral angles and stereospecific assignments 
for prochiral methylene protons were determined from 3D HNHB data (64) and short-
mixing time 2D NOESY spectra (65). Stereospecific assignments for the prochiral methyl 
groups of Leu and Val residues were obtained from a sample fractionally labeled with 
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10% 13C-glucose (70).  NMR spectra were collected on a Varian Inova 600 MHz 
instrument equipped with a cryogenic probe.  The NMR structure of Sma0114 was 
calculated using the program X-PLOR (v. 3.851) (34) based on 1627 experimental 
restraints (Table 3-1). The 20 lowest energy structures have been deposited in the PDB 
under accession code 2LPM.  
 
NMR Structure Determination for BeF3- activated Sma0114 
 Chemical shifts for the Sma0114•Ca2+ binary complex were obtained from the 
titration of 1H-15N crosspeaks in 2D 1H-15N HSQC spectra of Sma0114 as a function of 
CaCl2 concentration (31). NMR assignments for the Sma0114•Ca2+•BeF3- ternary 
complex were made from 2D and 3D NMR experiments as previously described for the 
apo protein. Distance restraints for structure calculations were obtained from 3D 15N- and 
13C-edited NOESY experiments (64) collected on a Varian Inova 800 MHz instrument, 
and a 2D 1H-NOESY experiment for the aromatic protons recorded at 600 MHz. The 
mixing time for all NOESY experiments was 150 ms. Hydrogen bonds were identified 
from deuterium isotope exchange experiments recorded on the ternary complex dissolved 
in 99.96% D2O. Hydrogen bond donors were identified as those residues seen in 
1H-15N 
HSQC spectra after deuterium isotope exchange. The protection pattern for the activated 
state was compared to that seen in the inactive enzyme and no changes were identified. 
We therefore determined that the hydrogen bond donors and acceptors did not change 
due to activation. Backbone φ and ψ dihedral angles were calculated from the assigned 
HN, Hα, N, Cα, Cβ and C’ chemical shifts using the program DANGLE in CCPNMR-
analysis (71).    
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Figure 5-1 (A) 1H-15N HSQC of the free protein (black) and the Ca2+ - bound protein 
(red). (B) 1H-15N HSQC of the Ca2+ - bound (red) and the BeF3- activated protein (green).   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 The NMR structure of the activated Sma0114•Ca2+•BeF3
-
 ternary complex, was 
calculated using the program X-PLOR (v. 3.851) (34) based on 1791 experimental 
restraints (Table 4-1).  Calculations were performed using Ca2+, Be, and F atomic radii 
from the X-PLOR library (34) to include the divalent metal ion and BeF3-. Because there 
are no literature examples available for a bond between Ca2+ and BeF3
-, we set the 
distance restraint between the two atoms at 2.35 Å, equal to the sum of the ionic radii for 
Ca2+ (0.99 Å) and F- (1.36 Å). The distance restraint was given an uncertainty bound of 
0.1 Å and the three fluorine atoms in BeF3
- were treated as ambiguous. We next included 
an ambiguous restraint of 1.5 ± 0.3 Å between the two sidechain carboxylic acid oxygens 
of Asp60 (OD1 or OD2) and the beryllium atom. The restraint was based on distances 
between the beryllium atom and the closest oxygen of the equivalent aspartate in 
representative X-ray structures of receiver domains (PDB codes: 1FWQ, 2A9O, 2PL1, 
3NNN). Bond distances in these structures ranged from 1.5 to 2.0 Å, with an average 
distance of 1.7 Å. We used the same approach to restrain the three possible Ca2+ ligands 
in the protein, Glu15-Asp16-Glu17. An analogous stretch of two, or three acidic residues 
in a row is found in the receiver domain structures listed above. To determine which of 
the three acidic residues in Sma0114 could be ligands for Ca2+, we carried out structure 
calculations with the distance restraint set for the complete structure but excluding 
restraints to Ca2+ or BeF3
-. Superimposition of the two structures showed that both Glu15 
and Asp16 were within bonding distance of the Ca2+ atom in the structures calculated 
without restraints to the ligands. These two residues are also within bonding distance to 
the Ca2+ atom in the apo enzyme, determined from a comparison of the NMR structures 
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of inactive and activated states (31). That is, the two residues already appear to be 
positioned to bind the metal in the inactive apo state. Glu17 points away from the Ca2+ 
atom but the conformation of this residue is poorly defined due to R2 line broadening. 
We therefore decided to also include Glu17 as a potential Ca2+ binding ligand. Distance 
restraints were set to 2.45 ± 0.15 Å based on literature values of typical bonds between 
carboxylic acid groups and Ca2+ in known protein structures (72), which range between 
2.3-2.6 Å. The distance restraints where treated as ambiguous with respect to the oxygens 
bound to the Ca2+ atom: Glu15 (OE1 or OE2), Asp16 (OD1 or OD2), and Glu17 (OE1 or 
OE2). Finally, we introduced a restraint of 2.5 ± 0.5 Å between the NZ atom of Lys105 
and the fluorine atoms of BeF3
-, which were treated as ambiguous in the calculations. An 
analogous lysine is found bound to BeF3
- in all BeF3
- activated receiver domain 
structures, with a bonding distance between 2.8 and 3.0 Å. To test the effect of this 
restraint we calculated a set of structures in which only the Lys105-BeF3
- restraint was 
removed. Without the restraint, the lysine sidechain was positioned in the interior of the 
structure but the distance of 6.0 Å to BeF3
- precluded a bonding interaction. Given that a 
buried charged lysine would be highly energetically unfavorable (73) as there are no 
other nearby negatively charged groups that could complement the positive charge on 
Lys105, we felt the restraint to the BeF3
- ion was justified. The restraints from the protein 
to the Ca2+ and BeF3
- ligands described above, introduced no violations in the structure 
calculations. The RMSD between the structures calculated with and without restraints to 
the ligands was 0.80 Å, comparable to the 0.88 Å value for the spread in the ensemble of 
  73 
activated state NMR structures (Table 4-1). This indicates that the derived restraints to 
the ligands do not affect the overall structure, and that the structure with the restraints to 
the ligands is compatible with the experimental NOE, hydrogen-bond, and dihedral 
restraints. The 26 lowest energy structures for the activated state of Sma0114 have been 
deposited in the PDB under accession code 2M98.  
 
 NMR Relaxation Measurements 
 Backbone dynamics of Sma0114 were investigated using 15N R1, R2 and 1H-15N 
NOE experiments.  Longitudinal relaxation rates (R1) were characterized using 
relaxation delays of 0.02, 0.05, 0.13, 0.21, 0.31, 0.5, 0.71 and 1.0 s. Transverse relaxation 
rates (R2) were measured using relaxation delays of 0.01, 0.03, 0.05, 0.07, 0.09, 0.15, 
0.25 and 0.35 s. 1H-15N NOE values were determined from experiments in which the 
proton signals were saturated (s) for 4 s and control experiments (c) in which the 
saturation period was replaced by an equivalent preacquisition delay. Spectra were 
acquired in an interleaved manner on a Varian Inova 600 MHz instrument for all three 
relaxation data sets. Relaxation rates were calculated from least-squares fits of the data to 
an exponential decay model (Eq. 1) where I is the intensity for the relaxation period τ, I0 
is the initial amplitude and R1,2 corresponds to the relaxation rate R1 or R2.  
 
I = I0exp(-τ/R1,2)        Equation 1 
 
Experimental uncertainties in relaxation parameters were taken as the standard errors of 
the fits. 1H-15N NOE values were calculated according to Equation 2, where I(s) is the 
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crosspeak intensity in the experiment with saturation (s) and I(c) is the crosspeak 
intensity without saturation (c).  
 
NOE = I(s)/I(c)         Equation 2 
The errors for the 1H-15N NOE experiment were determined as described previously  (57, 
74).  R1, R2 and 1H-15N NOE values were used as input for Model-Free calculations (42) 
using the program Tensor2 (32).  
  
Bioinformatics Analysis of Sma0114  
  Analysis of 273 HWE-kinases collected from the MiST 1 database (75) showed 
that 88 of the kinases had associated receiver domains. Receiver domains were 
considered to be associated with an HWE-kinase if the genes were fused or immediately 
upstream or downstream of the kinase.  The cognate receiver domains of the 88 HWE-
kinases identified in this way, were analyzed using the secondary structure prediction 
program PsiPred (v 2.6) (43).  The final alignment excluded 5 of the 88 sequences 
because they were less than 100 amino acids in length and did not appear to encode full-
length receiver domains.  As a control, 8 receiver domain sequences of known structure 
were employed in the alignment to verify that the α5/β5 motif could be detected 
accurately by PsiPred (43).  
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Chapter 6. Future Directions 
 
 Identifying the downstream target that Sma0114 interacts with remains a key 
objective. Complementary genetic and bioinformatics work on the downstream function 
of Sma0114 is underway. A deletion mutant removing the gene for Sma0114  
(Δsma0114) led to increased gene transcription in S. meliloti whereas deleting the 
Sma0113 HWE-kinase (Δsma0113) and a double mutant (Δsma0113sma0114) led to no 
change in gene transcription. Taken together these data show that Sma0114 requires 
functional Sma0113, its cognate histidine kinase, in order to exert its phenotype. Current 
studies building off of these results suggest that the primary role of Sma0114 is to inhibit 
Sma0113. The working theory is that phosphorylation of Sma0113 induces the 
phosphorylation of Sma0114 and leads to dissociation of the two proteins. Once 
Sma0114 is dissociated from Sma0113, Sma0113 is able to activate another receiver 
domain protein. Genetic analysis should be performed to identify other receiver domain 
partners that may be involved in a phospho-relay with Sma0113 once the kinase is 
phosphorylated. 
 In light of the fact that the inhibition of Sma0113 may be the primary role of 
Sma0114, further studies on the structure of Sma0113 should be performed. A necessary 
first step is to make Sma0113 soluble because its insolubility has precluded analysis of 
the enzyme's structure and function. The role of the His, Trp and Glu residues important 
in the HWE-kinase subfamily should also be explored in Sma0113. Mutants for these 
residues should be designed. In this way parallel mutant experiments can be compared to 
those done for the HWE-kinase BphP2 (18) to determine the importance of the three 
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residues in phospho-transfer. In BphP2 point mutations for each HWE residue eliminated 
autophosphorylation (18), so that we would expect to see a similar profile in Sma0113. 
Structural analysis of Sma0113 would enable an in-depth study of the role of each residue 
in the 3-dimensional form of the enzyme. Comparison of HWE-kinases to the histidine 
kinase superfamily would also be accomplished by solving the structure of Sma0113. 
Furthermore, titrating Sma0113 into 15N-labelled Sma0114 and recording changes in the 
1H-15N HSQC of Sma0114 can help define the interface between the two enzymes.  
 In order to explore the role of Lys105 in Sma0114 as the conduit of 
communication between the active site and 455 face, the residue should be mutated. A 
Lys105Arg mutant can be designed to maintain a positive charge at the position to test if 
any basic residue will function as a conduit. A Lys105Leu mutant would allow us to 
further test the importance of the positive charge at that position. In these mutants the 
ability to bind BeF3- as well as conformational changes in the 455 face should be 
determined. 15N relaxation experiments can be used to explore ps-ns dynamics and 
compare S2 order parameters of wildtype Sma0114 and Lys105 mutants.   
 The role of residues in the PFxFATGY motif should also be explored via 
mutagenesis. The Thr, Gly and Tyr residues that form the C-terminal end of the motif and 
form the beginning of Lβ4β5 should be explored as they precede the dynamic loop 
replacing helix α4 in Sma0114. Point mutations for each residue should be tested for the 
ability to bind BeF3- and any changes in Sma0113 inhibition. Further NMR studies 
including a 1H-15N HSQC and 15N relaxation should be performed to identify changes in 
conformation and dynamics as a result of the mutations.  
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Reprinted from Sheftic et al. (76) 
I performed kinetic assays and electron microscopy (Figures A1-1, A1-2, A1-3)  
Jessica Snell performed NMR experiments (Figure A1-4) 
Dr. Suman Jha performed ITC experiments (FigureA1-5) 
 
Appendix One. Misfolding of SEVI Inhibited by Physiological Metal 
Ions  
 
 
Abstract 
 
 SEVI (semen derived enhancer of viral infectivity), a naturally occurring peptide 
fragment of prostatic acid phosphatase, enhances HIV infectivity by forming cationic 
amyloid fibrils that aid the fusion of negatively charged virions and target cell 
membranes. Cu(II) and Zn(II) inhibit fibrillization of SEVI in a kinetic assay employing 
the fibril-specific dye Thioflavin T. Transmission electron microscopy (TEM) suggests 
that the metals do not affect fibril morphology. NMR shows that the metals bind to 
histidines 3 and 23 in the SEVI sequence. Isothermal titration calorimetry (ITC) 
experiments indicate that SEVI forms oligomeric complexes with the metals. 
Dissociation constants are micromolar for Cu(II) and millimolar for Zn(II). Because the 
Cu(II) and Zn(II) concentrations that inhibit fibrillization are comparable to those found 
in seminal fluid the metals may modulate SEVI fibrillization under physiological 
conditions. 
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Introduction 
SEVI is a naturally occurring 39-residue (4.6 KDa) proteolytic fragment of human 
prostatic acidic phosphatase (PAP248-286) that was discovered in a screen of semen 
compounds for effects on HIV infectivity (77). The SEVI peptide is present at a 
concentration of ~35 µg/ml in semen, and can assemble into amyloid fibrils with a cross 
β-sheet structure at concentrations above 2 µg/ml (77). The fibrils attach to virions and 
facilitate their fusion to target cells, thereby increasing HIV infectivity up to 400,000-fold 
(77). As such, the SEVI peptide could be an important facilitator of HIV transmission. 
The positively charged amyloid fibrils formed by SEVI are thought to promote 
viral fusion by reducing electrostatic repulsion between negatively charged virus and 
target cell membranes (77-79). The activity of SEVI appears to be general, in that it 
promotes cell-fusion of a variety of HIV variants (77) as well as human XMRV, a 
retrovirus that may play a role in prostate cancer (80). SEVI also boosts infectivity 
nonspecifically for a number of other retroviruses - a finding that may have applications 
to therapeutic gene transfer (81). The generality of the charge-screening mechanism is 
further emphasized by the observation that designed peptides, with sequences unrelated 
to SEVI, retain the ability to enhance HIV infectivity as long as they assemble into fibrils 
with cationic surfaces (82).  
Semen contains a very complex mixture of compounds (77, 83-85). It has been 
shown recently that anionic buffer molecules in human seminal plasma accelerate 
fibrillization (86), whereas other components such as proteases inhibit fibrillization by 
degrading SEVI (84). In this work, we focus on how SEVI fibrillization is affected by 
heavy metals since these are found at large concentrations in seminal plasma and have 
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been shown to modulate the fibrillization of other amyloidogenic proteins and peptides 
including Aβ (87), amylin (88, 89), α-synuclein (90), β-microglobulin (91), insulin (92), 
and prion protein (93).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  80 
Results  
Cu2+ and Zn2+ Inhibit SEVI Fibrillization 
Figure A1-1 shows the effects of increasing CuCl2 (Figure A1-1A) and ZnCl2 
(Figure A1-1B) concentrations on SEVI fibrillization. Both metals inhibited fibrillization 
compared to control samples of SEVI with a 5 mM concentration of the metal chelator 
EDTA. Additional control experiments were used to establish that the presence of EDTA 
had no effect on the fibrillization kinetics. The Zn2+ and Cu2+ ions are good ligands for 
histidines (88), which are present at positions 3 and 23 in the SEVI amino acid sequence. 
In addition to these metals, the effects of 1 mM Ca2+ and Mg2+ which are poor ligands for 
histidine imidazole rings (88) were explored. Inhibition of fibrillization was observed 
with 1 mM MgCl2 although to a lesser extent than with CuCl2 or ZnCl2. By contrast, 
CaCl2 had negligible effects compared to the control samples without metals. 
Nucleation of a fibrillization reaction is entropically disfavored due to the loss of 
rotational and translational degrees of freedom when monomers aggregate. The lag phase 
of the fibrillization curve represents the period of time before nucleation occurs. Once a 
critical mass or nucleus forms, the reaction enters a growth phase in which addition of 
monomers becomes enthalpically favorable as new non-covalent interactions form during 
the fibril elongation process. The reaction ultimately reaches a steady state plateau 
determined by the solubility of the monomers. The effects of Zn2+ and Cu2+ on the kinetic 
parameters characterizing SEVI fibrillization reactions (lag times, elongation rates, and 
plateaus) are shown in Figure A1-2. The most striking effect is seen on the lag times for 
fibrillization (Figure A1-2A). These increase 4 to 8-fold in the presence of the metals 
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compared to control samples containing SEVI alone, suggesting that the nucleation part 
of the reaction is inhibited in the presence of metals. 
The lag times show a constant 4-fold increase with Cu2+ concentrations in the 
range between 0.001 – 0.1 mM, consistent with a low dissociation constant for Cu2+ (see 
ITC section below). At the largest concentration of 1 mM CuCl2, there is a reversion to 
shorter lag times but these nevertheless remain about 2-fold longer than for SEVI without 
metals. Lag times also increase with increasing Zn2+ concentrations, reaching a plateau at 
0.1-1.0 mM ZnCl2. The data are consistent with a Zn2+ dissociation constant in the range 
of ~1 mM,  a value some 3 orders of magnitude larger than that for Cu2+. 
At the lowest 0.001 mM concentrations of Cu2+ and Zn2+ tested, there is a two-
fold reduction in fibril elongation rates compared to SEVI alone. This suggests that in 
addition to interfering with nucleation the metals hinder the addition of SEVI monomers 
to growing fibrils. As the metal concentration is increased up to 1 mM, however, the 
elongation rates show no further decrease, within experimental uncertainty (Figure A1-
2B). When the fibrillization reactions enter a steady state, the fluorescence plateaus show 
a slight decrease with increasing Cu2+ concentrations, whereas they increase with 
increasing Zn2+ concentrations (Figure A1-2C). Experiments done with a lower SEVI 
peptide concentration of 1 mg/ml showed the same increase in lag times and decrease in 
rates but the fluorescence plateaus were decreased for both Cu2+ and Zn2+. Fluorescence 
plateaus often correlate with the amount of fibrils formed but can also be influenced by 
differences in fibril morphology that affect interactions with the dye ThT. 
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Figure A1-1  Inhibition of SEVI fibrillization with increasing concentrations of (A) 
CuCl2 and (B) ZnCl2. All experiments were done with 2 mg/ml SEVI in PBS buffer, pH 
7.4 at a temperature of 37°C. Error bars are the standard errors of the mean values 
calculated from triplicate runs and are shown every tenth point for clarity. 
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Figure A1-2  Semi-logarithmic plots showing the CuCl2 (black) and ZnCl2 (gray) 
concentration dependence of kinetic parameters for SEVI fibrillization derived from the 
data in Figure A1-1. (A) Lag times. (B) Fibril growth rates. (C) ThT fluorescence 
plateaus. Uncertainty bars represent the standard errors from kinetic parameters of 
experiments run in triplicate. The horizontal lines marked “control” are ranges for 
parameters obtained from SEVI experiments without metals. 
  84 
Even if the larger fluorescence plateaus in the presence of 0.01-1.0 mM Zn2+ are due to 
larger numbers of fibrils in the presence of large Zn2+ concentrations, the lag times under 
these conditions are increased eight to nine fold (Figure A1-2A) so that Zn2+ would be a 
potent inhibitor of fibrillization on physiological timescales. 
 
Fibril Morphology is Retained but the Amount of Fibrils is Lowered in the Presence of 
Zn2+ and Cu2+ 
 Having established that Zn2+ and Cu2+ inhibit fibril formation, we next wanted to 
see if the metals affected the morphologies of the fibrils. Figure A1-3 compares control 
SEVI fibrils formed in the absence of metals (Figure A1-3A) to fibrils formed in the 
presence of 1 mM ZnCl2 (Figure A1-3B) or CuCl2 (Figure A1-3C). High magnification 
TEM images show that the metals have no apparent effects on fibril morphology (Figure 
A1-3). Lower magnification images given in the insets for Figure A1-3 suggest that the 
amount of SEVI fibrils is reduced in the presence of 1 mM ZnCl2 or CuCl2 compared to 
the control. 
 
NMR Mapping Identifies the Two Histidines in SEVI as the Ligands for Zn2+ and Cu2+ 
Previous NMR studies reported that the SEVI peptide is intrinsically unfolded at 
37°C but folds into an α-helical structure in 50% trifluoroethanol similar to that of the 
corresponding 248-286 segment in the parent protein human prostatic acid phosphatase 
(94). The changes in the NMR spectrum accompanying binding of diamagnetic zinc to 
SEVI are manifested as line-broadening, caused by intermediate exchange between the 
free and bound forms of the peptide. To better characterize the binding site, 2D 1H-15N 
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HSQC spectra of a 3 mM SEVI sample at natural isotopic abundance were acquired. 
Spectra were recorded in the absence of metals, in the presence of a 2:1 peptide:Zn2+ 
ratio, and at a 1:1.3 peptide:Zn2+ ratio (Figure A1-4A). Losses in 1H-15N HSQC 
crosspeak volumes due to intermediate exchange between the free and bound peptide are 
localized to residues 2-6 and 23-24, flanking the two histidines at positions 3 and 23.  
Line broadening is observed at substoichiometric concentrations of Zn2+, and 
there are only small additional decreases of crosspeak volumes as the metal concentration 
becomes saturating. The magnitude of the line broadening effects is similar for the 
regions surrounding His3 and His23, suggesting the two histidines bind Zn2+ 
simultaneously (Figure A1-4B). Consistent results implicating His3 and His23 as the 
ligands for Zn2+ were seen in 1H-13C HSQC spectra of SEVI, except that less residues 
could be analyzed due to the poorer chemical shift dispersion in the carbon spectrum. We 
obtained analogous results for the binding of paramagnetic Cu2+ to SEVI except that a 
larger number of crosspeaks were broadened in the 1H-15N HSQC and 1H-13C HSQC 
spectra. Although the sequence profiles are less well-defined than with Zn2+, the NMR 
data show that His3 and His23 also serve as the ligands for Cu2+. 
 
ITC Shows SEVI Forms Oligomeric Complexes with Cu2+ and Zn2+ 
ITC experiments were conducted to obtain information on the stoichiometry and 
thermodynamics of metal binding (Figure A1-5). The titration for Cu2+ is well-defined 
and indicates that the metal binds with a substoichiometric Cu2+/SEVI ratio of n = 0.3 and 
a dissociation constant of 2 µM (Figure A1-5A).  
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Figure A1-3  TEM images of SEVI fibrils. Images at 150,000x magnification. Control 
experiment showing SEVI fibrils grown in the absence of metals (A), in the presence of 1 
mM ZnCl2 (B), and in the presence of 1 mM CuCl2 (C). The insets for each panel show 
images obtained at a lower magnification of 11,000x.  
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Figure A1-4  Effects of ZnCl2 on the NMR spectrum of SEVI. (A) The three 
superimposed natural 15N abundance 1H-15N HSQC spectra in the absence of zinc (black 
contours), 1.5 mM ZnCl2 (green contours) and 4 mM ZnCl2 (red contours). NMR 
assignments for SEVI in blue text indicate peaks that are unaffected and in purple text for 
residues that experience NMR signal broadening in the presence of zinc. (B) Plot of 
crosspeak volume loss (%) with ZnCl2, as a function of residue position in the SEVI 
sequence.  
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The value of n = 0.3 suggest SEVI binds Cu2+ as a trimer, in which His3 and His23 from 
three SEVI monomers constitute the ligands of an octahedral metal coordination site. ΔG 
and ΔS values for the Cu2+ binding reaction were -32.5 ± 1.6 kJ/mol and 39.9 ± 5.4 
J/(molK) respectively.  
 The ITC data indicates that SEVI binds Zn2+ three orders of magnitude weaker 
than Cu2+. We obtained an apparent dissociation constant of 1.7 ± 0.9 mM, however, this 
value is subject to considerable uncertainty due to weak affinity of SEVI for Zn2+. ΔG 
and ΔS values for the Zn2+ binding reaction were -15.8 ± 8.4 kJ/mol and -163 ± 234 
J/(molK) respectively. Similarly, the n-value obtained from ITC of 0.45 ± 0.40 indicates 
substoichiometric binding but does not allow us to establish precisely how many SEVI 
molecules are bound to a Zn2+ ion. Whereas Cu2+ prefers octahedral or planar 
coordination in proteins (95), tetrahedral coordination is preferred for Zn2+ and octahedral 
coordination is rare (96).  
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Figure A1-5  ITC experiments. Cu2+ (A) and Zn2+ (B) binding to SEVI.  Upper panels 
show the heats evolved during the titrations. Lower panels show the enthalpy changes 
with increasing metal:SEVI mole fraction. The data were fit to a single binding site 
(independent binding) model. 
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Discussion 
 
These data show that Zn2+ and Cu2+ inhibit SEVI fibril formation (Figures A1-1, 
A1-2) but do not affect fibril morphology (Figure A1-3). Inhibition is achieved by 
coordinating the two histidines at positions 3 and 23 in the SEVI sequence (Figure A1-4). 
Cu2+ is more effective in inhibiting SEVI fibrillization than Zn2+ and this correlates with 
the tighter binding of the former metal ion to SEVI (Figure A1-5).  
The normal concentrations of Cu2+ in human semen is 1-3 µM (83, 97), 
comparable to the Kd of 2 µM determined for binding of the metal to SEVI by ITC 
(Figure A1-5A). Zinc concentrations in seminal plasma are about 2.5 mM (0.16 g/L) (83, 
85, 97), higher than in any other body fluids or tissues (83, 98). Although Zn2+ has a large 
Kd of 2 mM (Figure A1-5B), the concentration of zinc in semen should be sufficiently 
high to bind SEVI under physiological conditions. The inhibition of SEVI fibrillization 
by metals could be relieved when the peptide is transferred to a different environment 
following intercourse. It has been previously shown that the ability of SEVI to enhance 
HIV infectivity is retained in the acidic environment of the vaginal tract (77). In the 
vaginal tract, the concentrations of Cu2+ and Zn2+ are smaller than in semen (99, 100) and 
the acidic pH of 4.2 (77) would reduce affinity for these metals due to protonation of the 
histidine ligands.  
Cu2+ and/or Zn2+ have been reported to inhibit the fibrillization of a number of 
amyloidogenic peptides and proteins including amylin (88, 89), insulin (92), Aβ (101), 
and prion protein (93). A common theme that emerges from these studies is that the 
metals inhibit fibrillization by coordinating disordered segments of the polypeptide 
chains and inducing oligomeric structures that are not competent for fibril assembly. For 
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amyloidogenic precursors that exist as folded globular proteins, such as transthyretin, a 
possible strategy to inhibit fibrillization is to develop molecules that bind and thereby 
stabilize the native state (102). The present work, as well as previous work on the 
inhibition of amyloidogenic proteins by metals (88, 89, 92, 93), suggests that compounds 
that bind and stabilize non-native structures incompatible with fibril assembly may 
provide an avenue for the development of inhibitors of amyloidogenic polypeptides that 
are intrinsically unfolded. 
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Materials and Methods 
Preparation of SEVI Peptide 
SEVI was purchased as a custom-synthesized peptide from Biopeptide (San 
Diego, CA). The samples were 95% pure by HPLC and had a peptide content of 70%. 
Samples were received as lyophilized powders and resuspended in 100% dimethyl 
sulfoxide (DMSO) to make stock solutions of 100 mg/ml peptide. The stock solutions 
were kept at -80°C when not in use. For experiments, SEVI stocks were diluted in the 
desired buffers to a final concentration of 4% (v/v) DMSO. CuCl2, ZnCl2, MgCl2, and 
CaCl2 were from Sigma. EDTA was from Fisher. All buffers were prepared with Milli-Q 
water and filtered through a 0.22 µm Millipore filter before use. Buffers for monitoring 
fibril formation were additionally treated with Chelex-100 to remove trace metals, 
according to the manufacturer’s instructions (Bio-Rad, Hercules CA).  
 
SEVI Fibril Formation Kinetics 
Fibril kinetic assays were conducted in white 96-well clear-bottom Corning 
Costar plates (Lowell, MA) sealed with clear polyester tape to prevent evaporation. 
Unless otherwise specified, 200 µl samples were used with 2 mg/ml of SEVI in pH 7.4 
PBS buffer (8 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl and 140 mM NaCl). The 
SEVI concentration used for this work is lower than the 5-10 mg/ml typically used in 
previous studies (77, 79, 103, 104). The peptide concentration was chosen as a 
compromise between peptide cost and the time required to complete fibrillization, since 
reproducibility worsens with increasing reaction times (105). We examined a series of 
SEVI concentrations between 0.1 and 5 mg/ml and found that the ThT fluorescence 
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plateaus for the fibrillization reactions scale nearly linearly, except at high peptide 
concentrations where nonspecific aggregation may start to compete with fibrillization 
(92).  
The phosphate buffer used in this work poses the potential problem of 
precipitating metals, as well as forming complexes which reduce the free metal ion 
concentration (106, 107). The precipitating phosphate (PO43-) ion forms with a pKa of 
12.6, so that at a physiological pH of 7.4 its concentration will be only 0.006% of the 
total phosphate concentration, namely 0.6 µM for 10 mM phosphate buffer (106). 
Consistently, we saw no visible precipitation of the samples even at the highest 1 mM 
metal concentrations used in our PBS buffer. Because the metals can form soluble 
complexes with H2PO4- and HPO42- ions, however, the effective free metal concentration 
in solution may be as much as 10-fold lower than the total metal concentration (107). As 
an alternative to phosphate, we conducted experiments in 20 mM Tris with 150 mM 
NaCl (TBS) buffer at pH 7.4, and saw a dependence on CuCl2 concentration similar to 
that observed in PBS. The amount of fibrils formed in TBS buffer for control samples 
that had no metals, however, were about 7-fold lower than in PBS based on the ThT 
fluorescence plateaus at the end of the reaction. The time for completion of the reactions 
increased about 6-fold in TBS compared to PBS at the same SEVI peptide concentration. 
Tris, like phosphate, can associate with divalent metals (106). In 20 mM HEPES with 
150 mM NaCl pH 7.0, which is a Good buffer (108) that should have minimal 
interactions with metals, we detected a 10-fold lower ThT fluorescence plateau and a 3-
fold increase in reaction times. These results are consistent with a recent report that SEVI 
fibrillization is markedly enhanced in anionic buffers such as phosphate (86). We thus 
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used PBS buffer for SEVI fibrillization studies because it consistently gave the best 
results, and because this buffer most closely replicates physiological conditions (85).  
In addition to SEVI peptide and buffer, each fibrillization reaction had a 15 µM 
concentration of the amyloid-specific dye ThT to detect fibrils (109), a 0.02 % (v/v) 
concentration of NaN3 to prevent bacterial growth during the fibrillization reactions, and 
a Teflon bead which improves reproducibility by providing more efficient mixing of the 
reaction components (105, 110). The plates were maintained at a temperature of 37°C 
throughout the experiments. A continuous agitation speed of 240 rpm was used for the 
reactions. While agitation is necessary for SEVI to form fibrils (77, 104) we found that 
increasing the agitation speed from 240 to 1,200 rpm had no effects on fibril formation 
kinetics. Fibrillization reactions were carried out in triplicate to obtain estimates on the 
uncertainties of kinetic parameters. The fluorescence of ThT was measured every 30 min 
on a Fluoroskan Ascent plate reader (Franklin, MA) using excitation at 440 nm and 
emission at 490 nm (109). Lag times and rates for fibrillization reactions were obtained 
from non-linear least-squares fits of the data to a published 6-parameter equation (111). 
Reaction plateaus were determined from the fluorescence maxima when the reactions 
first reached a steady-state. At longer times, once fibrils have formed, the solution is no 
longer homogeneous so that the fluorescence values can become unreliable (112). 
 
Transmission Electron Microscopy (TEM) 
Samples for TEM were prepared from 1 mg/ml solutions of SEVI incubated with 
continuous agitation for 15 days in PBS buffer at pH 7.4 and a temperature of 37°C. The 
samples contained 1 mM concentrations of either ZnCl2 or CuCl2. We also looked at 
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control samples without metals and 5 mM EDTA. ThT fluorescence was used to confirm 
that all fibrillization reactions had reached the plateau stage prior to imaging by TEM. 
Samples were applied to 400 mesh carbon coated copper grids and negatively stained 
using 1% uranyl acetate. The samples were applied in 4 µl aliquots to the grids, rinsed 
with 1 µl of H2O, and excess liquid was wicked from the grid using filter paper.  To stain 
the samples, 4 µl of 1% uranyl acetate was applied for 45 sec and the excess stain was 
wicked off with filter paper. Electron micrographs were obtained using a FEI Tecnai G2 
BioTWIN instrument, which is part of the UConn TEM facility. 
 
 NMR Spectroscopy for SEVI 
NMR data were collected on a 600 MHz Varian Inova spectrometer equipped 
with a cryogenic probe. The experiments were preformed on 3 mM samples of SEVI in 
90% H2O/10% D2O. The pH was adjusted to 5.5 or 7.4 using aliquots of 1 M HCl and 
NaOH solutions. The temperature for the experiments was 10°C to avoid loss of amide 
proton signals through solvent exchange. NMR assignments were obtained using 2D 
experiments from the Varian Protein Pack. Residue-type assignments were obtained from 
70 ms mixing time TOCSY experiments and sequential assignments were made from 300 
ms mixing time NOESY spectra. These were supplemented with 1H-15N HSQC and Cα-
selective 1H-13C HSQC spectra collected on samples at natural isotopic abundance to 
obtain 13C and 15N assignments. The NMR samples under quiescent conditions were 
stable at 10°C as monitored by 1D NMR spectra collected before and after 2D NMR 
experiments. NMR assignments have been deposited in the BioMagResonBank (BMRB) 
under accession numbers 17924 (SEVI) and 17925 (SEVI with 4 mM ZnCl2). To 
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characterize line broadening in the presence of ZnCl2 and CuCl2, crosspeak volumes in 
1H-13C HSQC and 1H-15N HSQC spectra were measured with the “integrator” utility of 
the iNMR software (Mestrelab Research). 
 
Isothermal Titration Calorimetry (ITC) for SEVI 
Experiments were done at 25°C on a Nano ITC low-volume calorimeter (TA 
Instruments, New Castle, DE). Samples were prepared in 20 mM Tris buffer at pH 7.5 
containing 150 mM NaCl (TBS buffer). For the Cu2+ experiment, the SEVI concentration 
was 200 µM and the starting ligand concentration was 1 mM CuCl2. Due to weaker 
binding, the experiment with Zn2+ necessitated a SEVI concentration of 400 µM and a 
starting ligand concentration of 2 mM ZnCl2. Since Zn2+ has a low solubility at basic pH, 
the 2 mM ZnCl2 solution in 20 mM TBS buffer was prepared by serial dilution, starting 
from a 200 mM ZnCl2 stock solution prepared in de-ionized water. All solutions were 
filtered through 0.2 µm filters and degassed under vacuum for 15 min. Control titration 
experiments to obtain the heat of dilution were performed by titrating TBS solutions of 1 
mM CuCl2 or 2 mM ZnCl2, into TBS buffer without protein. The control experiments 
showed that contributions from enthalpy changes due to dilution were negligible (ΔH < -
1.0 kJ/mol). ITC data were analyzed with NanoAnalyze software (v. 2.1.13). 
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Reprinted in part from Sheftic et al. (113) 
Appendix Two. Ionization Constants of Free and Micelle-Bound 
Amyloid-β 
 
Abstract 
 Amyloid- beta (Aβ) is thought to contribute to the pathology of Alzheimer's 
disease and like many amyloid peptides may exert cytotoxic effects at cell membranes. It 
is therefore important to study the properties of these proteins in membrane-like 
environments.  The membrane mimetics most amenable for high-resolution structural 
studies are micelle monolayers because at least some of the micelles are sufficiently 
small for NMR studies. An understanding of the contribution of electrostatic interactions 
to the structural stability of Aβ in the micelle-bound and intrinsically unfolded native 
states is critical in achieving a more complete understanding of its structure and 
dynamics.  Owing to the fact that the individual contributions of charged residues as well 
as individual point charges are prominent forces governing intra- and intermolecular 
interactions we characterized pKa values for ionizable residues in free and micelle-bound 
Aβ using NMR.  
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Introduction 
 Electrostatic forces play important roles in protein folding, stability and 
association (114). Charged functional groups can also contribute to enzymatic activity 
and conformational transitions (114-117). A better understanding of electrostatic forces 
provides information on biological mechanisms ranging from structure formation to 
molecular recognition, and could lead to improved potential energy functions for protein 
structure prediction and design (118-123).  
 NMR spectroscopy is unique in that it can measure ionization constants (pKa 
values) with site-specific resolution (124). The protonated and unprotonated states of 
ionizable residues are almost always in fast exchange on the NMR timescale (125) so that 
a population-weighted average of the charged and neutral species is observed. At high 
pH, the population-averaged chemical shift is dominated by the unprotonated form. As 
the pH is lowered, the resonance position of the titrating site gradually shifts towards the 
chemical shift of the protonated form, eventually reaching an acidic chemical shift 
plateau as the population of the protonated form dominates. The pH value at the mid-
point of the sigmoidal titration curve is the pKa value for the site in question. The pKa 
value is typically determined from a non-linear least-squares fit of the NMR chemical 
shift vs pH data to the model specified by the Henderson-Hasselbalch equation (116, 
124). Although the majority of ionization equilibria are in fast exchange on the NMR 
timescale, there are some exceptions. Histidine resonances sometimes broaden at pH 
values near their pKa consistent with intermediate exchange between the protonated and 
unprotonated species (126). For the vast majority of cases, however, ionization equilibria 
are in fast exchange on the NMR timescale.   
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Many of the proteins involved in amyloidogenic diseases such as amyloid-beta 
(Aβ), amylin, and α-synuclein (αS) function as membrane-bound proteins, or may exert 
their cytotoxic effects through membrane bound forms (127, 128). Characterizing the 
properties of these proteins in membrane-like environments has become vital. To this end 
we decided to determine the pKa values of Aβ-40 (the 40 residue Aβ peptide) in sodium 
dodecyl sulfate (SDS) micelles. The structure of the peptide bound to SDS micelles is 
known and other biophysical studies have been performed (129).   The present study 
describes the measurement of ionization constants in Aβ by NMR spectroscopy. 
Inferences are obtained from these experiments into the roles of charges in stabilizing the 
folded structure of the peptide.  
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Results 
pH Titration of Aβ-40 via NMR  
 A series of 1H-15N HSQC spectra recorded as a function of pH can provide a 
straightforward and sensitive way to obtain titration data for charged amino acids (116, 
130). Figure A2-1 illustrates 1H-15N HSQC spectra recorded during a pH titration of 
monomeric Aβ-40 free in solution. NMR chemical shifts can be easily measured with 
very high accuracy relative to an internal reference compound such as DSS or TSP (66). 
From the pH series chemical shifts were derived for ionizable residues in Aβ-40. Figure 
A2-2 shows representative titration curves for Glu11 in Aβ-40 where chemical shifts 
were recorded as a function of pH. 
 
Interpretation of pKa Values in Terms of Stability 
The foundation for interpreting pKa data in terms of protein stability is the 
thermodynamic linkage cycle shown in Figure A2-3, where F is the folded state, FH is 
the protonated folded state, U is the unfolded state, and UH is the protonated unfolded 
state (131).  The vertical arrows describe the change in free energy on folding or 
unfolding (∆GF or ∆GU).  The horizontal arrows describe equilibria related to the 
protonation of a residue in the folded (∆GFH) or unfolded state (∆GUH).  The contribution 
of a charge to protein stability, is therefore given by equation 1 (132, 133):  
 
    ∆∆Gtitr = -2.303RT *(pKaU - pKaN)    
           (1) 
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Figure A2-1 1H-15N HSQC spectra of Aβ-40. Each spectrum was recorded at a different 
pH and chemical shifts were monitored for perturbations. Note that there are no spectra 
shown for basic pH values (>8.0) where there is a loss of amide proton peaks because of 
base-catalyzed exchange with the solvent. All spectra shown were recorded in the 
absence of SDS micelles at a temperature of 20°C.    
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Figure A2-2  Titration of Glu11 using observed chemical shifts as a function of pH.  (A) 
Chemical shifts recorded in the absence of SDS micelles for HN and N nuclei. (B) 
Chemical shifts recorded in the presence of 100 mM SDS for HN and N nuclei.  
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where R is the gas constant, T is absolute temperature, pKa U is the pKa of a site in the 
unfolded state (Table A2-1) and pKa N is the pKa of a site in the folded state (Table A2-1). 
The pKa value of each ionizable site was used to estimate the free energy contribution 
from protonation to the stability of the folded state using thermodynamic linkage, as 
shown in Figure A2-3B (116, 131, 134).  
 
Results with Micelle Bound Aβ-40 
 The pKa data for free Aβ-40 and for the peptide bound to SDS micelles are 
summarized in Table A2-1. Similar data have been previously obtained for a 1-28 residue 
fragment of Aβ (135). We wanted to see if residues 29-40 in the naturally occurring 40-
residue fragment Aβ-40 affected the pKa values. Our data for Aβ-40 are in very good 
agreement with those previously reported for the 1-28 fragment. The two exceptions are 
His6 and Glu11 in the SDS bound form of the peptide. For His6 we think the chemical 
shift of the high pH form in the previous study (135) was probably misassigned to 
formate, a common and almost ubiquitous impurity in NMR samples that resonates at 
8.44 ppm.  With our assignment of the high pH plateau of the Hε proton of His6 to 7.7 
ppm, the pKa value for His6 becomes very close to those of the other two histidines.  The 
other small change is that we obtain a pKa of 6.14 for Glu11 from the pH-dependence of 
its backbone amide proton chemical shift. In the previous report for the 1-28 fragment a 
pKa of 5.5 was obtained from the γ-methylene resonances of Glu11 (135).  Our correction 
for Glu11 brings its pKa closer to those of other glutamates in Aβ-40 (Table A2-1). 
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Figure A2-3  Shift in pKa values between folded and unfolded states and the calculation 
of a change in folding free energy from a change in charge (∆∆Gtitr).  (A) Titration data 
illustrating the pKa shift for Lys8 between the folded and unfolded states of the GCN4p 
coiled coil (116).  In this case the positively charged state of Lys8 stabilizes the GCN4p 
structure; the side-chain becomes protonated at a lower hydronium ion concentration in 
the native state (pKa 11.3) compared to the unfolded state (pKa 10.6).  (B) The 
thermodynamic cycle that can be used to quantify the contribution of a change in charge 
to a change in stability.  U is the unprotonated unfolded state, UH is the protonated 
unfolded state, F is the unprotonated folded state, FH is the protonated folded state, and R 
is the gas constant.  ∆∆Gtitr needs to be multiplied by -1 for acidic groups, and by the 
number of magnetically equivalent monomers if used for an oligomeric protein.  In the 
present example, for Lys8 in the GCN4p coiled coil dimer ∆∆Gtitr = -1.9 
(kcal/mol•dimer) at a temperature of 25oC. 
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The pKa values for free and micelle bound Aβ-40 as well as the ∆∆Gtitr values are 
summarized in Table A2-1. We see large and uniform pKa shifts when the protein is 
bound to SDS corresponding to ∆∆G values of a magnitude between 1.2 and 2.7 kcal/mol 
at 20°C.  For groups that become positively charged when ionized, the contributions are 
favorable likely reflecting attractive interactions with the sulfate headgroups of SDS.  
For groups that become negatively charged on ionization the thermodynamic 
contributions are unfavorable, most likely due to electrostatic repulsion with the 
negatively charged sulfate headgroups of the micelles.  Another system we looked at is 
the unique histidine at position 50 of αS (Figure A2-4).  It is worth noting that αS prefers 
binding to membranes with a high proportion of negatively charged lipids so the 
negatively charged SDS micelles in this case should be a better model than neutral DPC 
micelles (136). We identified a large pKa shift from 6.33 for the free protein to 7.26 for 
the protein bound to SDS micelles.  The larger pKa in the presence of SDS indicates 
His50 takes up a proton at smaller hydronium ion concentrations presumably because of 
electrostatic attraction between the positively charged histidine and the negatively 
charged sulfate groups on the SDS micelle. 
 The pKa shift in His50 of αS corresponds to an energetically favorable ∆∆Gtitr of -
1.3 kcal/mol at 37°C. By contrast in neutral DPC micelles the pKa is raised only to 6.59, 
corresponding to a ∆∆Gtitr of  -0.4 kcal/mol. There appears to be a residual interaction, 
possibly involving a weak ion pair between Glu46 and His50 but its contribution to the 
stability of the folded structure is much smaller than that between His50 and the 
negatively charged micelle sulfate groups of SDS.  The pKa values for Aβ-28 bound to 
DPC micelles have been reported previously (135) and for all 10 ionizable residues 
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investigated large pKa shifts were observed when the peptide was bound to negatively 
charged SDS micelles. By contrast, when bound to neutral DPC micelles the pKa values 
for Aβ-28 were similar to those of the unstructured peptide in D2O (135). 
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Table A2-1  Ionization constants for Aβ(1-40) and free energy contributions to the 
stability of the SDS micelle-bound structure. 
Residue pKa free pKa SDS ∆∆Gtitr 
(kcal/mol)  
Resonance  H2O/D2Ob 
N-term 8.11 ± 0.64 7.99 ± 0.15 0.16 ± 0.88 Asp 1 (Hβ1,2) D2O 
Asp 1 3.79 ± 0.40 5.43 ± 0.11 2.19 ± 0.56 Ala 2 (H) H2O 
Glu 3 4.62 ± 0.34 6.17 ± 0.12 2.08 ± 0.48 Glu 3 (H) H2O 
His 6 6.77 ± 0.03 7.87 ± 0.05 -1.47 ± 0.08 His 6 (Hε1) D2O 
Asp 7 4.20 ± 0.12 5.55 ± 0.09 1.81 ± 0.20 Asp 7 (H/N) H2O 
Tyr 10 11.42 ± 0.22 12.30 ± 0.05 1.18 ± 0.30 Tyr 10 (Hε1,2) D2O 
Glu 11 4.40 ± 0.31 6.15 ± 0.13 2.34 ± 0.45 Glu 11 (H) H2O 
His 13 6.67 ± 0.02 7.72 ± 0.07 -1.41 ± 0.10 His 13 (Hε1) D2O 
His 14 6.65 ± 0.02 7.82 ± 0.05 -1.57 ± 0.07 His 14 (Hε1) D2O 
Lys 16c 10.50 ± 0.24 > 12.5 < -2.5  Lys(Hε1,2-Hδ1,2) D2O 
Glu 22 4.13 ± 0.07 6.12 ± 0.04 2.66 ± 0.11 Glu 22 (H) H2O 
Asp 23 4.25 ± 0.10 5.52 ± 0.04 1.70 ± 0.14 Asp 23 (N/H) H2O 
Lys 28c 10.5 ± 0.24 > 12.5 < -2.5 Lys(Hε1,2-Hδ1,2) D2O 
C-term 3.72 ± 0.09 5.25 ± 0.02 2.41 ± 0.12 Ala 40 (H/N) H2O 
 
 All data were collected at a temperature of 20°C in the absence of added salts.  For the 
values of the peptide bound to SDS micelles, the SDS concentration was 100 mM. 
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Figure A2-4  Titration curves of His50 from αS in various solvents.  All data were 
collected at 37°C.  For the micelle samples the concentrations of SDS and DPC were 100 
mM. 
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Discussion 
In summary, binding of proteins to SDS micelles appears to induce large shifts in 
pKa values. For negatively charged amino acid sidechains the shifts indicate energetically 
unfavorable interactions due to electrostatic repulsion. For positively charged amino acid 
sidechains the pKa shifts indicate energetically favorable interactions between opposite 
charges. The magnitudes of the shifts appear to be similar in the different systems we 
looked at (Aβ and αS), and while they show some dependence on residue type (Table A2-
1) they show little dependence on the location of the ionizable group in the amino acid 
sequence or in the 3-dimensional structure.  The pKa shifts of the glutamate residues 
investigated are uniformly larger than those of the histidines (Table A2-1).  The location 
of glutamate residues in the sequence, however, did not affect pKa shifts observed 
suggesting that the perturbations seen were independent of sequence position. This is 
important, because residues 1-14 are unstructured in micelle bound Aβ, while residues 
15-36 fold into an α-helical structure with a kink between residues 25-27 (129). 
Moreover, paramagnetic relaxation enhancement spin-label experiments show that the 
segments 15-24 and 29-35 reside on the surface and in the interior of the micelle, 
respectively; while the unstructured segments 1-14 and 36-40 are solvent exposed.  The 
pKa shifts for Aβ are insensitive to the differences in structural properties and to the 
positioning of the different parts of the polypeptide with respect to the micelle (137).   
 Taken together these observations suggest that SDS micelles act as polyanions 
and provide an electrostatic screen for the entire peptide, that appears to be independent 
of structure and the degree of immersion of the polypeptides into the micelle.  In other 
words, this screening appears to be non-specific with respect to structural context. In the 
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case of DPC micelles we expected that if ion pairs within Aβ provided large stabilizing 
forces we would see large pKa shifts between the free and bound forms. However, the 
results with DPC micelles show that pKa values are similar for bound and free protein 
(135) where the neutral character of these micelles would not provide electrostatic 
screening. This strongly suggests that electrostatic interactions within the protein are 
small, compared to those between the protein and the charged micelles. 
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Materials and Methods 
Aβ-40 Preparation for NMR 
 Natural abundance Aβ-40 was from EZBiolab (Camel, IN) and 15N labeled Aβ-40 
was purchased from rPeptide (Bogart, GA).  NMR data were collected at a temperature of 
20°C on a 600 MHz Varian Inova instrument equipped with a cryogenic probe in the 
absence of added salts.  For experiments with micelles, the SDS concentration was 100 
mM.  For experiments in H2O, data were obtained by following the indicated backbone 
amide resonances using 1H-15N HSQC experiments.  At high pH the experiments no 
longer work because of rapid amide proton exchange.  For experiments in D2O we 
followed resonances either using 1D 1H NMR for the aromatic residues, or 2D TOCSY 
for the aliphatic protons.  For experiments with micelles we used natural abundance SDS 
in H2O and d25-SDS in D2O. 
 
pKa Measurements by NMR 
To precisely define a pKa value, a titration series of about 10 – 15 spectra are 
collected at different pH points. For more demanding experiments it may be possible to 
obtain a pKa value with a greater experimental uncertainty from about 6-8 pH points.  
The most important parts of the titration curve to define are the midpoint, and the acidic 
and basic plateaus.  When planning an experiment it is therefore important to sample pH 
points near the pKa and to define the acidic and basic plateaus, by collecting one or two 
pH points far from the pKa.  
Because of sample losses from pipetting and pH measurements a larger sample 
volume larger than necessary, 0.7 mL for a standard 5 mm NMR tube, was used. The pH 
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adjustments were made using stock solutions of acid and base, typically at 1 M 
concentrations. The acid and base solutions were delivered using 0.2 to 2.0 µl aliquots. 
For titrations in D2O, it was necessary to use DCl and NaOD to avoid introducing H2O 
into the sample. The pH electrode was also rinsed in 99.8% D2O before pH 
measurements, to avoid introducing H2O. The deuterium isotope effect on the pKa is 
about 0.4 pH units. It is known, however, that it is approximately equal and opposite in 
sign to the deuterium isotope effect on glass electrodes so that no correction was needed 
for titrations in D2O compared to H2O (124).  
Electrode 2- and 3-point calibrations against pH 4, 7, and 10 buffers were 
performed for accurate results. The pH of the sample was measured both before and after 
collecting an NMR spectrum, and the average between these two values was used as the 
experimental pH. Typically the difference between the pH measured before and after the 
NMR experiment was within 0.1 to 0.2 pH units. There are two different types of pH 
electrodes available.  Glass electrodes have the advantage of having extensive literature 
on corrections for the effects of isotopes on the pH measurements and for the effects of 
denaturants such as urea (116, 124, 138, 139). Metal electrodes have the disadvantage 
that the effects of isotopes or denaturants on pH measurements are not as well 
characterized as for glass electrodes.  Glass electrodes have a particular disadvantage 
when working with SDS detergent micelles. The potassium salt of SDS is highly 
insoluble, so even a trace amount of KCl from the storage solution of a glass electrode 
invariably leads to precipitation of some of the micelles.  To avoid any precipitation 
metal electrodes were used exclusively when studying Aβ-40 in the presence of 
detergents or lipids. 
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Analysis of pKa Values 
The data from the pH titration series were analyzed using a non-linear least-
squares fit to the Henderson-Hasselbalch equation 2 (124, 140): 
    
       (2) 
 
where pKa is the ionization constant, δlow is the low pH chemical shift plateau, δhigh is the 
high pH chemical shift plateau, and n is the apparent Hill coefficient. With these four 
parameters it is possible to reconstruct the chemical shift of a titrating nucleus at any pH. 
The Hill coefficient parameter in principle should describe the cooperativity of the 
titration (124).  Values of n less than 1 suggest negative cooperativity. Values of n greater 
than 1 suggest positive cooperativity (124, 141).    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Appendix Three. Visualizing Amyloid-β Complexes   
 
Abstract 
 The amyloid-beta (Aβ) peptide is linked to the onset and progression of 
Alzheimer's disease. Two isoforms of the peptide are present in cerebrospinal fluid (Aβ-
40 and Aβ-42). The two peptides differ by two C-terminal residues due to variances in 
sequential proteolysis reactions of the amyloid precursor protein (APP). Despite their 
strong sequence homology the two peptides have markedly different behavior in vitro and 
in vivo. Aβ-42 forms the cross β-sheet amyloid fibril structures at a much faster rate than 
Aβ-40 whereas Aβ-40 is found in 10-fold higher concentrations in vivo. Interestingly, the 
two peptides also co-localize in amyloid deposits in vivo. In order to explore the possible 
association of the two peptides into a single amyloid fibril total internal reflection 
fluorescence (TIRF) microscopy was used. The preliminary work here shows that 
monomeric Aβ-42 forms fibrils that are shorter when grown in the presence of 
monomeric Aβ-40. It is unclear whether the two peptides co-localize into a single 
structure but this data shows that Aβ-40 affects the fibrillization of Aβ-42 by possibly 
acting to inhibit the addition of monomeric Aβ-42 to the growing ends of fibrils once the 
reaction is in the fibril elongation phase.  
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Introduction  
 Proteins can fold into a native conformation as well as misfold into a non-native 
state. Often proteins can form new misfolded structures that impart detrimental functions.  
A well-studied class of such proteins is the amyloid family.  Amyloids are protein 
aggregates that have a cross β-sheet structure in which each β-strand is stacked 
perpendicular to the fibril axis (142, 143). Proteinacious aggregates are believed to 
disrupt normal cellular activity and are often a pathological hallmark of a variety of 
diseases (144, 145) including Parkinson's Disease, Prion disease and Alzheimer's Disease 
(146).  
 Although it is unclear how these proteins transform into fibrils of ordered β-sheet 
structure, amyloid fibril formation follows nucleation kinetics (147, 148).  The kinetics of 
the reaction can be monitored using ThioflavinT (ThT) assays that can be used to 
determine variables including reaction rates and lag times (Figure A3-1). ThT is an 
exogenous fluorescent dye that binds specifically to the cross-beta sheet structure unique 
to amyloid fibrils (149).   
 The amyloid beta (Aβ) peptide is a byproduct of the sequential proteolytic 
cleavage of the transmembrane amyloid precursor protein (APP). Two isoforms, the 40-
mer and 42-mer, are the most common products of APP cleavage (150, 151). 
Cerebrospinal serum Aβ-42 is detected at about 10-fold lower levels than Aβ-40 but can 
accelerate the aggregation of Aβ-40 (152).  It has been shown that altering the ratio of the 
two peptides by increasing the amount of Aβ-42 relative to Aβ-40 causes a decrease in 
the lag phase for Aβ-40 fibrillization (153).  More specifically, when the ratio of Aβ-40: 
Aβ-42 is 7:3 the toxicity of the fibrils formed is increased (152).  The amount of Aβ-42 
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present in cerebrospinal fluid is strongly correlated with Alzheimer’s disease. The 
increase in Aβ-42 relative to Aβ-40 in familial mutants leads to an early onset of the 
disease (152). The ratio of Aβ-42 relative to Aβ-40 is also used as a diagnostic tool for 
separating Alzheimer's disease from non-Alzheimer's disease related dementia (154, 
155).  
  Amyloid fibrils formed by the association of a single protein can have a variety of 
morphologies, posing the possibility that multiple reaction pathways for aggregation are 
possible (156).  It is possible that the two Aβ peptides can be incorporated into a single 
growing fibril due to their strong sequence similarity.  Furthermore, Aβ fibrils formed by 
the incorporation of both peptides may have different morphologies wherein an increase 
of Aβ-42 relative to Aβ-40 may prompt the reaction to favor fibrils of a different 
morphology.  The hetero or homogeneity of a fibril during growth can be imaged using 
total internal reflection fluorescence (TIRF) microscopy (157, 158).  Determining if both 
peptides are incorporated into a single fibril may shed light on why changes in the ratio 
between Aβ-40 and Aβ-42 leads to changes in the rate of fibril formation (150).  
Complimentary studies by TEM can provide information on the morphology of the fibrils 
formed in the presence of both peptides.   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Figure A3-1  Representative amyloid fibrillization reaction monitored by ThT 
fluorescence. The reaction is characterized by three phases: the lag phase in which the 
protein remains monomeric until a critical nucleus is formed, the growth phase in which 
the energetic losses in rotational and translational entropy are compensated by enthalpic 
increases due to the addition of monomeric protein to a protofibril structure and the 
plateau phase in which an apparent steady-state between growing fibrils and free 
monomers is reached. 
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Results 
Microscopy of Aβ-40 and Aβ-42 Peptides 
 Control experiments were used to generate kinetic reaction curves using ThT 
assays of the peptides conjugated to fluorescent dyes (Figure A3-2). The Aβ-40 peptide 
was conjugated to HyLyte Fluor 488 (Aβ-40-488) and Aβ-42 was conjugated to HyLyte 
Fluor 555 (Aβ-42-555). The sigmoidal transition for Aβ-40-488 (Figure A3-2A) appears 
inverted when compared to the curve generated from a ThT assay in the absence of other 
fluorescent dyes (Figure A3-1). The reaction inversion is likely due to Förster resonance 
energy transfer (FRET) between the ThT and attached HyLyte fluor dye wherein ThT 
excitation is absorbed by the conjugated 488 dye. A similar inverted profile is seen for 
Aβ-42-555 (Figure A3-2B) albeit the absence of a detectable lag phase. Due to fast 
aggregation of Aβ-42 it is likely that the lag time between the preparation of the peptide 
and the first ThT measurement was longer than the lag time for fibrillization. To confirm 
the presence of fibrils from reactions using Aβ-40-488 and Aβ-42-555 transmission 
electron microscopy (TEM) images were collected (Figure A3-3). The conjugated dyes 
do not appear to affect fibril formation or morphology. For comparison, Aβ-40 fibrils 
formed without conjugated dyes and in the absence of the exogenous ThT dye are shown 
in Figure A3-4.  
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Figure A3-2 ThT kinetic assays for Aβ-40-488 (A) and Aβ-42-555 (B). Blue curves 
represent 20 µM and 10 µM peptide concentrations in (A) and (B) respectively. Pink 
curves represent 40 µM and 20 µM peptide concentrations in (A) and (B) respectively. 
Green curves represent 80 µM and 40 µM peptide concentrations in (A) and (B) 
respectively.  
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Figure A3-3 TEM images of Aβ-40-488 (A) and Aβ-42-555 (B). All images were 
collected at 49,000X magnification. Samples were negatively stained with 1% uranyl 
acetate on 400 mesh carbon-coated copper grids.  
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Figure A3-4 TEM images of Aβ-40 fibrils at 11,000X magnification. Fibrils in the inset 
were imaged at 49,000X magnification. Monomeric Aβ-40 was incubated in 20 mM 
Na2HPO4 pH 7.4 for 14 days prior to imaging. Fibrils were negatively stained with 1% 
uranyl acetate on 400 mesh carbon-coated copper grids. 
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 TIRF microscopy on Aβ-42-555 shows long extended fibrils similar to those seen 
in TEM images. TIRF on Aβ-40-488 shows more diffuse fibrils that are difficult to image 
above the baseline noise (Figure A3-5) and when both peptides are in a reaction mixture 
it is very difficult to see Aβ-40-488 signal. Due to the diffuse nature of Aβ-40-488 fibrils 
we used an excess of Aβ-42-555 relative to Aβ-40-488 to obtain better images. The 
peptide ratio of 2:1 Aβ-42-555:Aβ-40-488 has been successfully imaged using TIRF. In 
the images in Figure A3-6 it is clear that the length of the Aβ-42-555 fibrils in the 2:1 
Aβ-42-555:Aβ-40-488 reaction are shorter when compared to the Aβ-42-555 fibrils 
prepared alone. 
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Figure A3-5  TIRF microscopy of Aβ-40-488 fibrils formed in the absence of Aβ-42-
555. A monomeric concentration of 40 µM Aβ-40-488 was used to generate the fibrils. 
Fibrils were formed in a solution containing 20 mM Na2HPO4 with 50 mM NaCl and 
0.02% NaN3.   
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Figure A3-6  TIRF microscopy of Aβ-42-555. (A) 20 µM Aβ-42-555. (B) 20 µM Aβ-42-
555 with 10 µM Aβ-40-488. Both solutions contain 20 mM Na2HPO4 with 50 mM NaCl 
and 0.02% NaN3. 
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Discussion 
It is unclear at this point whether or not Aβ-40 and Aβ-42 co-localize into a 
heterogenous fibril. The diffuse fluorescence of Aβ-40-488 by TIRF could be the product 
of a lesser amount of fibrils formed in the reaction with this isoform. TEM of the Aβ-40-
488 peptide suggests that lower quantities of fibrils are formed when compared to the 
Aβ-42-555 peptide reaction (Figure A3-4). It is likely that the lack of fibrils formed by 
Aβ-40-488 translates into an inability for the fibril structures present to produce enough 
fluorescence to overcome background fluorescence in the samples used for TIRF. The 
enhanced quantity of fibrils formed from Aβ-42-555 visualized by TEM (Figure A3-4) 
translates into increased signal via TIRF (Figure A3-6).  
 TIRF of Aβ-42-555 suggests that at least the length of fibrils formed by Aβ-42 are 
shortened upon addition of Aβ-40. This is consistent with previous work that suggests 
that the addition of Aβ-40 monomers to Aβ-42 monomers increases the lag time for 
fibrillization (159) and decreases toxicity (160). As such the data presented here supports 
a reaction where nucleation and fibril elongation are affected by the interaction of the two 
isoforms. The shortened fibrils formed could lessen the density of fibrillar deposits in 
vivo, which could lead to decreased cellular damage particularly at the membrane surface 
thus decreasing toxicity. 
 In future studies the diffuse nature of the Aβ-40-488 fibrils should be explored 
further. The 488 dye itself may be responsible for the diffuse fluorescence seen from 
TIRF microscopy. One way to test the dye is to switch the 488 and 555 dyes on the Aβ-
40 and Aβ-42 peptides, that is to say Aβ-40 should be conjugated to the 555 dye and Aβ-
42 should be conjugated to the 488 dye. TIRF microscopy would then reveal if the 
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diffuse fluorescence is a property of the 488 dye or the Aβ-40 peptide. Furthermore, TEM 
images of the mixed peptide reactions should be collected to confirm the TIRF finding 
that Aβ-42 fibril lengths are decreased when they are formed in the presence of 
monomeric Aβ-40. These studies will lay a foundation for studying the impact of several 
different ratios of Aβ-40 and Aβ-42 on fibril heterogeneity and morphology.  
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Materials and Methods 
Fluorescently Tagged Aβ Preparation 
 Samples were prepared from 0.1 mg HyLyte Fluor Aβ-40-488 and 0.1 mg HyLyte 
Fluor Aβ-42-555 purchased from Anaspec (San Jose, CA). HyLyte Fluor Aβ-40-488 was 
dissolved in 1% NH4OH per the manufacturers instructions to a final concentration of 
435 uM. Likewise, HyLyte Fluor Aβ-42-555 was dissolved in 1% NH4OH to a final 
concentration of 385 uM. The peptide solutions were then sonicated in a cold water bath 
at 70% amplitude for 5 minutes. Stock solutions were immediately diluted to 
concentrations of 10-80 µM in white 96-well clear-bottom Corning Costar plates (Lowell, 
MA) sealed with clear polyester tape to prevent evaporation. Stock solutions were always 
made fresh on the day of use. Fibrillization reactions were carried out in 20 mM 
Na2HPO4 buffer at pH 7.4 with 50 mM NaCl and 0.02% NaN3. All solutions were filtered 
with 25 µm syringe filters. Fibrillization reactions were allowed to progress at room 
temperature for 20 days before TIRF imaging. For ThT experiments, ThT was added to a 
final concentration of 15 µM. ThT was purchased from Anaspec.  
 
Aβ Kinetics and TEM 
 ThT fluorescence assays conducted at 25°C were used to confirm that fibrils were 
formed from the tagged peptides. The kinetic profiles were inverted from typical reaction 
curves. Assuming fluorescent interference, namely FRET, was responsible, TEM images 
were taken of the peptides to confirm fibril formation. Samples were applied to 400 mesh 
carbon coated copper grids and negatively stained using 1% uranyl acetate. The samples 
were applied in 4 µl aliquots to the grids, rinsed with 1 µl of H2O, and excess liquid was 
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wicked from the grid using filter paper.  To stain the samples, 3 µl of 1% uranyl acetate 
was applied for 45 seconds and the excess stain was wicked off with filter paper. Electron 
micrographs were obtained using a FEI Tecnai G2 BioTWIN instrument.  
 
TIRF Chamber Preparation 
 In order to perform TIRF microscopy, solutions need to be contained in a very 
thin area or "chamber" created between two different glass surfaces with different 
refractive indices. In order to create these chambers a glass coverslip (Fisher Cat. No. 12-
542-C; Pittsburg, PA) was sealed to a glass slide (Fisher Cat. No. 12-544-I; Pittsburg, 
PA) leaving a very thing space between the two surfaces. In order to create the chamber 
space clear sealant was applied to the slide and the coverslip was then placed ontop of the 
sealant as it dried. The thin space formed between the coverslip and slide was able to 
hold up to 50 uL of solution. Prior to sealing, the glass surfaces both were cleaned using 
1% w/v Alconox detergent and then subsequently rinsed with deionized water. Both 
surfaces were cleansed with 70% v/v ethanol and allowed to air dry immediately before 
sealant was applied.    
 
TIRF Microscopy 
 Samples were prepared as described above albeit no ThT was used for TIRF 
experiments. Fibril containing samples were injected in 30-40 uL aliquots to chambers 
created as described above. Slides were inverted for imaging on an Andor Revolution XD 
Spinning Disk Confocal instrument with a Nikon TiE inverted microscope.  Excitation 
filters of 488 and 560 nm were used to image Aβ-40-488 and Aβ-42-555 respectively. 
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Images were recorded with an Andor 897 iXon EMCCD camera using an oil immersion 
TIRF lens (1.49 NA, 100X, Nikon) at a temperature of 25°C. 
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